ALEXANDRIA, Va., Dec. 28 /PRNewswire/ -- In applauding efforts by the Clinton Administration to police rogue Internet pharmacy operators and rogue physicians, the National Association of Chain Drug Stores suggests new regulatory proposals should be carefully evaluated. The Administration s objective is laudable, and we
LOS ANGELES, Dec. 24 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation today was officially advised that it world receive all proceeds resulting from Ty Inc. s Worldwide Beanie Baby Vote beginning on Dec. 31. This first of its kind global vote will determine the fate of Beanie Babies worldwide. We extend o
For the eighth year in a row, nearly 100 representatives from Congregation Shav ar Zahav and Jewish Family and Children s Services will be preparing festive holiday meals for Project Open Hand clients. The preparation, packaging and delivery of over 1,200 holiday meals will be done by the Jewish community on both Chris
NEWARK, N.J., Dec. 22 /PRNewswire/ -- As millions of last minute shoppers attempt to log on to commercial Internet sites to find that special gift for a colleague or family member, PricewaterhouseCoopers is quietly promoting a community-enhancing alternative: a visit to angelwish.org. The site, which offers online visi
NEW YORK, Dec. 21 /PRNewswire/ -- The Internet provides powerful tools to help increase treatment compliance among people with chronic conditions, according to findings released today by Cyber Dialogue. Data from Cyber Dialogue s Cybercitizen Health survey of American adults found that one-third of chronic disease suff
PRINCETON, N.J., Dec. 20 /PRNewswire/ -- A major new, international conference presenting the newest advances by the pharmaceutical industry in developing novel drugs to fight viral diseases, including respiratory/influenza, HIV, and hepatitis B & C, will take place on March 15-16, 2000 at the Hyatt Regency Hotel i
PHILADELPHIA, Dec. 16 /PRNewswire/ -- Hemispherx Biopharma, Inc. (Amex: HEB; HEBws) today announced that recent independent laboratory test results show potential advantages of its product Ampligen(R) when virologic failure occurs clinically with the presently available arsenal of anti-HIV drugs. According to findings
CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that its partner Glaxo Wellcome has received fast track designation for the HIV protease inhibitor VX-175/GW433908 from the United States Food and Drug Administration. Fast track designation is granted to p
WILMINGTON, Del., Dec. 16 /PRNewswire/ -- An article published today in The New England Journal of Medicine (Volume 341, Number 25) concludes that combination HIV therapy with DuPont Pharmaceuticals Sustiva (TM) ( efavirenz ) plus nelfinavir and two nucleoside reverse transcriptase inhibitors ha
PHILADELPHIA, Dec. 15 /PRNewswire/ -- A study headed by a physician at The Children s Hospital of Philadelphia has shown that a novel combination of drugs achieves strong, sustained results in controlling HIV infection in children, according to an article in the December 16 New England Journal of Medicine. Forty-eight
PHILADELPHIA, Dec. 14 /PRNewswire/ -- The U.S. Food and Drug Administration ( FDA ) has recognized the Centers for Disease Control and Prevention s (CDC) description of hepatitis B vaccines as preventing hepatitis B infections which can lead to primary liver cancer. SmithKline Beecham announced today that its Engerix-B
PRINCETON, N.J., Dec. 8 /PRNewswire/ -- Pharmaceutical industry advances in the discovery and development of novel antiviral agents in HIV, influenza/respiratory, and hepatitis B & C, will be presented in depth on March 15-16, 2000 at the Hyatt Regency Hotel in Princeton, NJ, announces Strategic Research Institute.
DURHAM, N.C., Dec. 10 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced that the Food and Drug Administration ( FDA ), following extensive discussions with the Company, has advised Triangle that it would need to conduct one or possibly two additional Phase III studies in order to prove that
BETHLEHEM, Pa., Dec. 9 /PRNewswire/ -- A new safety IV catheter that automatically shields the needletip after use could eliminate nearly 50,000 of the most dangerous accidental needlestick injuries faced by healthcare workers each year-those from hollow-bore IV needles that could be filled with blood containing infect
ALEXANDRIA, Virginia, Dec. 8 /PRNewswire/ -- The following statement is being issued by the National Association of Chain Drug Stores in response to President Clinton s announcement today of proposed measures to reduce medical errors. The statement is attributable to Craig L. Fuller, NACDS President and Chief Executive
SAN FRANCISCO, Dec. 7 /PRNewswire/ -- The Internet industry s premier awards program -- the prestigious Global Information Infrastructure (GII) Awards -- will recognize organizations that are utilizing the Internet to create a profound effect on the way that people live, work, learn and play. This year s winners will b
PHILADELPHIA, Dec. 6 /PRNewswire/ -- The Philadelphia AIDS Consortium today officially announced it was increasing its overall allocations to 51 community-based organizations by over $400,000. The increase for additional direct services to persons living with HIV/AIDS represents a 10% across-the-board hike to service p
Former South African President Nelson Mandela will join Bill Gates, co- founder of the Bill and Melinda Gates Foundation, and others in a Forum that will address the challenges of providing access to lifesaving medical advances for children in the poorest parts of the world. WHEN: Thursday, December 9; 10:00 AM WHER
SAN FRANCISCO, Dec. 3 /PRNewswire/ -- Providian Financial Corporation (NYSE: PVN) today announced that it has granted $20,000 to the Pediatric HIV Quality of Life Gift Fund, a nonprofit program administered by the UC San Francisco Pediatric AIDS Treatment Center. Established five years ago, the Fund is dedicated to mee
Teens who drink or use drugs are much more likely to have sex, initiate it at younger ages -- as early as middle school -- and have multiple partners, placing them at higher risk for sexually-transmitted diseases, AIDS and unplanned pregnancies, according to a new report to be released at 10 a.m. Tuesday, December 7 at
CHICAGO, Dec. 2 /PRNewswire/ -- As we count down to the Year 2000, the physicians of America know that the new millennium will bring tremendous challenges and opportunities in preventing illness and disease. New technology, tests and treatments will result in more accurate diagnoses and better outcomes for patients. Gr
WALL, N.J., Dec. 2 /PRNewswire/ -- Healthcare lawyers, market researchers and information professionals can now conduct free full-text searches among the largest collection of health and hospital case law on the Internet through the Healthcare Intelligence Network (http://www.hin.com). Visitors to the site can search t
WASHINGTON, Dec. 1 /PRNewswire/ -- Colthurst Limited and Patrick T. Prendergast, Ph.D., inventors and developers of several drugs to treat HIV, announced today that they have established the website http://www.colthurst.org. The website will allow a wider audience access to scientific publications relating to HIV treat
LOS ANGELES, Dec. 1 /PRNewswire/ -- Congressional representatives, activists, civil rights leaders, celebrities, church and community leaders, and people living with AIDS, converged at a National Town Hall Meeting today -- World AIDS Day -- in Los Angeles to introduce a first-of-its-kind approach to fighting the AIDS e
ST. PAUL, Minn., Dec. 1 /PRNewswire/ -- Pokeweed antiviral protein, a natural product isolated from the pokeweed plant, shows great potential as a new anti-AIDS drug when targeted to cells infected with the AIDS virus. In a clinical study, nine out of nine patients were treated with a single dose of this agent and tole
SAN DIEGO, Dec. 1 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced preliminary results from the first 13 patients treated with HE2000 in a Phase I/II HIV trial in South Africa . In this study, HE2000 administered as a monotherapy produced no serious drug-related adverse events and was ge
NEW YORK, Nov. 30 /PRNewswire/ -- New York City residents of all ages and ethnic backgrounds believe HIV/AIDS is the city s number one health problem according to a new survey of all five boroughs. More than half of the city s residents know one or more people that have died of AIDS or are currently living with AIDS or
NEW YORK, Nov. 29 /PRNewswire/ -- NY-World AIDS Day is Wednesday, December 1, and every major network and cable system across the country is uniting to promote HIV/AIDS awareness by telecasting AIDS-related programming and public service announcements (PSAs). The goal of this coordinated effort is to reach millions of
NEW YORK, Nov. 30 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation is pleased to join the Magic Johnson Foundation for a symposium and other activities related to World AIDS Day at the United Nations. The day s theme, Children Left Behind, will focus on children from around the world who have been orphane
Measure Requiring Condoms in West Hollywood Bars Revived As City Council Again Delays Compromise Action on Condoms Goal: Step up Prevention Efforts in West Coast Epicenter of HIV/AIDS WHAT: PRESS CONFERENCE/ Relaunch of Ballot Measure to Require Condoms in West Hollywood Bars AHF President Michael Weinstein, AHF s Gov
MINNEAPOLIS, Nov. 30 /PRNewswire/ -- Bruce, a patient at Abbott Northwestern Hospital s Clinic 42, takes a combination of HIV medications three times a day. Currently, he takes four anti-retroviral medicines -- a total of ten pills, plus one liquid medicine -- to fight his HIV infection. HIV medications are complicated
NEW YORK, Nov. 30 /PRNewswire/ -- At a high-level symposium at the United Nations this morning, business and economic experts predicted the AIDS story will soon move from the health pages to the business pages of the world s newspapers. Speaking at the Global Economics of HIV/AIDS: Defining Social and Business Costs sy
Kaiser Permanente Educational Theatre to Present Program that Provides Positive Role Models for Teens on World AIDS Day, December 1 WHAT: The Educational Theatre from Kaiser Permanente, Mid-Atlantic States, will perform Secrets, a live, 70-minute, interactive stage play about HIV/AIDS for 200 Eastern High School Studen
CAMBRIDGE, Mass., Nov. 29 /PRNewswire/ -- Therion Biologics Corporation has been awarded three contracts totaling $1.5 million from the NIH s National Institute of Allergy and Infectious Disease (NIAID) for the development and manufacture of novel AIDS vaccines and related research reagents, the company announced today
LA JOLLA, Calif., Nov. 29 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. today announced that the Food and Drug Administration ( FDA ) has approved twice daily dosing (BID) of VIRACEPT(R) (nelfinavir mesylate) for the treatment of HIV infection. Approval supports 1250mg BID dosing of VIRACEPT based on data that showed c
Who: Winners of the children s HIV/AIDS poster and essay contests will be recognized during a World AIDS Day ceremony at The Children s Hospital of Philadelphia. In addition, students from the School District of Philadelphia will entertain guests with music and dancing, while Teen Peer Educators from Children s Hospita
PHILADELPHIA, Nov. 29 /PRNewswire/ -- City officials and other invited guests will join We The People on World AIDS Day to open We The People West, the coalition s second neighborhood-based resource center for people living with HIV/AIDS in Philadelphia. Jannie Blackwell, in whose City Council District the project is l
An observance of World AIDS Day, The Children Left Behind , will be held at UN Headquarters on 1 December 1999 from 10 a.m. to 6 p.m. in Conference Room 4. -- Speakers and participants include: Theo-Ben Gurirab, President of the UN General Assembly Kofi Annan, UN Secretary-General Louise Frechette, UN Deputy Secretary-
PHILADELPHIA, Nov. 27 /PRNewswire/ -- INDEPENDENCE BLUE CROSS & INSIGNIA/ESG (Commercial Real Estate Corp) are the proud sponsors of the ActionAIDS -- ART for LIFE /Art Auction & Reception which will be held at IBC on Tuesday, November 30th, the Eve of World AIDS Day . ActionAIDS -- Pennsylvania s largest provi
BELTSVILLE, Md., Nov. 26 /PRNewswire/ -- An editorial published in the November 25 issue of The New England Journal of Medicine confirms that persistent human papillomavirus (HPV) infection causes cervical cancer and suggests that perhaps it is time to consider periodic screening for HPV in conjunction with screening f
LOS ANGELES, Nov. 23 /PRNewswire/ -- According to a report released today by the Joint United Nations Programme on HIV/AIDS ( UNAIDS ) and the World Health Organization (WHO), since the beginning of the epidemic, 50 million individuals worldwide have been infected with HIV, of whom more than 16 million have died and 33
SEATTLE, Nov. 23 /PRNewswire/ -- The Bill and Melinda Gates Foundation announced today a gift of $750 million over five years to help ensure that children in developing countries are immunized against major killer diseases in the new millennium. The gift represents the first contribution to a new initiative called the
While research and prevention efforts have achieved considerable progress, nearly 40 million people are now living with HIV/AIDS worldwide, and 16,000 become newly infected each day. Because HIV primarily affects people during their most economically productive years, the increasing human and economic costs of the epid
ATLANTA, Nov. 23 /PRNewswire/ -- On November 30, the Surgeon General will host the African American Community HIV/AIDS Satellite Conference and BlackFamilies.com, the nation s premier Web site for African American families, will make history as the first black Web site to Web cast an event of this type. BlackFamilies.c
REDMOND, Wash., Nov. 23 /PRNewswire/ -- A three-way collaboration between Queen, David Bowie and Microsoft Corp. (Nasdaq: MSFT) will mark World AIDS day, Dec. 1, 1999, with a global Internet-based AIDS fund-raising event. Through WindowsMedia.com, the MSN(TM) online guide to multimedia on the Internet, Microsoft will h
WASHINGTON, Nov. 23 /PRNewswire/ -- The National Football League Players Association (NFLPA), in a bold off-the-field move, has teamed up with Outreach, Inc., in a series of Public Service Announcements (PSAs) designed to inform the public, particularly the African-American community, about the dramatic increase in HIV
VENTURA, Calif., Nov. 23 /PRNewswire/ -- The Med-Design Corporation (Nasdaq: MEDC) announced today that The Centers for Disease Control (CDC) issued a very strongly worded safety alert yesterday advocating that all hospitals and other health care facilities use safety needles to protect health care workers from deadly
SAN FRANCISCO, Nov. 22 /PRNewswire/ -- Project Open Hand s work and its mission -- Meals with Love -- takes on special resonance during Thanksgiving, the holiday so closely associated with food. The kitchen at 730 Polk Street in San Francisco will be buzzing with activity as staff and volunteers prepare more than 800 t
WEST BRIDGEWATER, Mass., Nov. 22 /PRNewswire/ -- Boston Biomedica, Inc. (Nasdaq: BBII) announced today that BBI Biotech Research Laboratories (a wholly-owned subsidiary of Boston Biomedica) has been awarded a seven year $9.6 million specimen repository contract from the National Institute of Allergy and Infectious Dise
CHICAGO, Nov. 22 /PRNewswire/ -- AIDS prevention, state hotline numbers, and tips for talking about AIDS with children are just a few of the features on National PTA s web site devoted to the topic at http://www.pta.org/events/wad99 . For the third consecutive year, National PTA is providing these materials in anticipa
ORLANDO, Fla., Nov. 22 /PRNewswire/ -- The Health Network, the leading health destination on television and the Internet, will join Cable Positive, the cable industry s AIDS action organization, to increase awareness of HIV and AIDS on World AIDS Day, December 1, 1999. AIDS is now the second leading cause of death amon
VIENNA, Va., Nov. 22 /PRNewswire/ -- CEL-SCI CORPORATION (Amex: HIV) (Berlin Stock Exchange: LSR), in response to media questions in advance of World AIDS Day, releases the following statement. Frequently asked questions and answers are as follows: ** Do you have any results from your phase II HIV vaccine study? The HG
CLEVELAND, Nov. 22 /PRNewswire/ -- The Ohio Department of Health HIV/STD Prevention Program will commemorate World AIDS Day with a 2-day conference, End the Silence, on December 6 and 7, 1999, at the Fawcett Center on the Ohio State University campus in Columbus. The conference schedule includes five plenary sessions a
An observance of World AIDS Day, The Children Left Behind, will be held at UN Headquarters on 1 December 1999 from 10 a.m. to 6 p.m. -- Speakers and participants include: Theo-Ben Gurirab, President of the UN General Assembly Kofi Annan, UN Secretary-General Louise Frechette, UN Deputy Secretary-General Hillary Clinton
PHILADELPHIA, Nov. 19 /PRNewswire/ -- Health care providers and anyone affected by HIV can now access the latest information on approved and experimental HIV therapies online, it was announced today. The American Foundation for AIDS Research (amfAR) HIV/AIDS Treatment Directory, long considered one of the most comprehe
WHAT: In honor of Paddington Bear s 40th anniversary the Council of Fashion Designers of America presents a private VIP shopping spree at FAO Schwarz to benefit Elizabeth Glaser Pediatric AIDS Foundation Highlight of evening is live auction of Paddington Bear designed by Badgley Mischka WHO: On display will be Paddingt
VERNON HILLS, Ill., Nov. 18 /PRNewswire/ -- Immtech International, Inc. (Nasdaq: IMMT) a biopharmaceutical company focused on the discovery and commercialization of pharmaceutical treatments for infectious diseases such as tuberculosis, fungal diseases, pneumonia and diarrhea, and biological products to treat cancer an
SALT LAKE CITY, Nov. 18 /PRNewswire/ -- Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has identified a novel drug target for the treatment of HIV. The drug target represents a new approach to treating AIDS, and may enable the creation of an entirely new class of therapeutics, distinct from the
NEW YORK, Nov. 17 /PRNewswire/ -- It is estimated that as many as 100,000 young people in the United States between the ages of 13 and 21 are infected with HIV and most don t know it and are not receiving necessary life-prolonging health care. HIV. LIVE WITH IT. GET TESTED! a campaign that speaks directly to youth in t
NEW YORK, Nov. 17 /PRNewswire/ -- In celebration of World AIDS Day 1999, Levi s(R) Jeans and LIFEbeat, the Music Industry Fights AIDS, have partnered to present Music with a Message: World AIDS Day 1999, a benefit concert on December 1 to support HIV/AIDS education. Marking the twelfth anniversary of World AIDS Day, mu
SPRINGFIELD, Ill., Nov. 16 /PRNewswire/ -- State Senator Christine Radogno (R-24, LaGrange) announced a bi-partisan plan to address the health care needs of low-income older and adults and people with disabilities. The plan -- dubbed the 100% Campaign -- will increase access to Illinois state Medicaid program. Senator
TORONTO, Nov. 16 /PRNewswire/ -- Polydex Pharmaceuticals Ltd. (Nasdaq: POLXF) (BSE: PXL) is pleased to report that Phase I, safety and tolerance clinical study of Ushercell, was successfully completed with minimal evidence of vaginal irritation, by the Contraceptive Research and Development (CONRAD) Program. The projec
LOS ANGELES, Nov. 12 /PRNewswire/ -- A California Senate Hearing on hepatitis C today reviewed the Department of Health Services (DHS) and Department of Corrections handling of a little known, but deadly and pervasive virus -- hepatitis C. The spotlight revealed little action has been taken by either department to stop
CARLSBAD, Calif., Nov. 4 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced that an independent Data Safety Monitoring Board (DSMB) composed of European and U.S. scientists recommended that the trial in Spain of Remune(TM) (trial 2102) in patients infected with HIV continue to its conclusion
DENVER, Nov. 4 /PRNewswire/ -- WebMD and the National Minority AIDS Council (NMAC) have partnered to bring the third annual United States Conference on AIDS (USCA) to the Internet, beginning today. For the duration of the conference, WebMD will conduct live Webcasts of keynote speakers and plenary sessions via http://a
CHICAGO, Nov. 4 /PRNewswire/ -- Opening day ceremonies for the 1999 Parliament of the World s Religions will symbolize the relevance of religion and spirituality to issues facing South Africa and the world. The Dec. 1-8 event is expected to draw some 6,000 people from around the globe to Cape Town, South Africa s show
CARLSBAD, Calif., Nov. 3 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) announced today that data were presented at the Royal College of Physicians, London, England, showing that patients treated with REMUNE(TM), an immune-based therapy to treat HIV infection, exhibited a significant increase in lymphoc
SAN DIEGO, Nov. 3 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH) today announced that clinical data from studies with its lead compound, HE2000, will be presented at the 4th International Workshop on HIV, Cells of Macrophage Lineage, and other Reservoirs, to be held in Florence, Italy De
WASHINGTON, Nov. 3 /PRNewswire/ -- The rate of human immunodeficiency virus (HIV) infection among state and federal prisoners dropped from 2.3 percent in 1996 to 2.1 percent in 1997, according to a new bulletin released today by the Justice Department s Bureau of Justice Statistics (BJS). There were 23,548 HIV-infected
CHICAGO, Oct. 29 /PRNewswire/ -- Oak Brook resident Dr. Biswamay Ray, chairman of the annual fund raising dinner for the Council for a Parliament of the World s Religions (CPWR), reports that the organization netted some $100,000 from this year s event, held Sunday, Oct. 24, at Chicago s Palmer House Hilton. When the d
BRISBANE, Calif., Oct. 29 /PRNewswire/ -- VaxGen , Inc. (Nasdaq: VXGN) today announced that the federal Centers for Disease Control and Prevention (CDC) will contribute funds to support additional research at five of the 56 clinics in the United States currently conducting Phase III clinical trials of VaxGen s AIDSVA
MADISON, N.J., Oct. 28 /PRNewswire/ -- In a potentially major step against a lethal infectious disease, scientists at Schering-Plough Research Institute have identified the structure of an enzyme complex that is essential to replication of the hepatitis C virus (HCV). In an article published in the November issue of St
NEW YORK, Oct. 27 /PRNewswire/ -- For the third consecutive year, the advertising industry will host the Madison Avenue Sellout, an auction and garage sale of products and services donated by the advertising community to benefit AIDS services. The Madison Avenue Sellout will be held on November 3, 1999 at the Tent at L
WASHINGTON, Oct. 27 /PRNewswire/ -- MEE (Motivational Educational Entertainment) Productions Inc., an internationally-recognized communications firm targeting urban populations, has debuted its latest video production, Life is What You Make It(TM), designed to raise awareness of HIV/AIDS treatment options within Americ
WASHINGTON, Oct. 26 /PRNewswire/ -- The Department of Veterans Affairs (VA) is launching a new Center for Quality Management in HIV Care, a national working laboratory in Palo Alto, Calif., designed to promote innovation and improvement in the care of patients infected with the human immunodeficiency virus, which cause
DURHAM, N.C., Oct. 26 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today that it will present 24-week data from MKC 301, a pivotal study designed to assess the antiviral activity, safety and tolerability of Coactinon(R) (emivirine), formerly known as MKC-442, in treatment-naive HIV-infected p
LA JOLLA, Calif., and PEAPACK, N.J., Oct. 25 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. and Pharmacia & Upjohn , Inc. (NYSE: PNU) today announced that Agouron has acquired worldwide rights to Pharmacia & Upjohn s RESCRIPTOR(R) ( delavirdine mesylate tablets),
NEW YORK, Oct. 25 /PRNewswire/ -- It is estimated that at least 10,000 young people in New York City ages 13-24 are infected with HIV and most don t know it. HIV. LIVE WITH IT. GET TESTED!, an innovative campaign that speaks directly to young people in their own language, is being launched in response to this health em
WASHINGTON, Oct. 12 /PRNewswire/ -- Exploring the concept of working together -- both locally and globally -- will be the theme of the largest AIDS meeting in the United States -- the United States Conference on AIDS (USCA), scheduled for November 4-8 in Denver Colorado. More than 3,000 representatives from the nation
ATLANTA, Oct. 22 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously today to recommend Prevenar(, the first pneumococcal conjugate vaccine, for routine use in all healthy children up to age 5 with priority use in specific population
BOCA RATON, Fla., Oct. 21 /PRNewswire/ -- Nabi (Nasdaq: NABI) announced today that it has filed a New Drug Submission (NDS) with the Canadian regulatory authorities for Nabi-HB, Hepatitis B Immune Globulin (Human), in Canada . Nabi has been notified that this application will receive Priority Review. Upon completion o
CAMBRIDGE, Mass., Oct. 21 /PRNewswire/ -- The First International Conference on AIDS in Ethiopia is set to take place in Addis Ababa from November 6 - 10, 1999. The conference, organized under the banner Fighting for Life will bring together AIDS experts from around the world to discuss the expanding problem of AIDS in
RESEARCH TRIANGLE PARK, N.C., Oct. 21 /PRNewswire/ -- Patients with chronic hepatitis B who were treated with the oral antiviral medication Epivir (R)-HBV(TM) (lamivudine) were more likely than patients receiving placebo (sugar pill) to experience improvements in liver inflammation and other signs of hepatitis B virus
AUSTIN, Texas, Oct. 20 /PRNewswire/ -- Ambion, Inc. has been awarded a phase II SBIR grant for $808,000 from the National Institute of Allergy and Infectious Diseases (NIAID) to further the development of their Armored RNA(R) technology. The main application of this technology is to manufacture stable, robust RNA that
LOS ANGELES, Oct. 20 /PRNewswire/ -- On Friday, October 22, 750 people from Southern California will board United Airlines flights taking them to Washington DC to run the Marine Corps Marathon on Sunday, October 24. Most of the runners are first time marathoners, some living with HIV, some running in memory of loved on
What: To kick off Get Tested Week, the Adolescent HIV Initiative at The Children s Hospital of Philadelphia will host a Youth Town Meeting entitled The Miseducation of Generation X -- HIV and AIDS: What you need to know. Who: Youths between the ages of 13 and 24 are invited to attend this high-energy event. Bret Rudy,
CHICAGO, Oct. 20 /PRNewswire/ -- Two prominent South Africans will address the annual dinner for the Council for a Parliament of the World s Religions (CPWR). More than 500 supporters will attend the annual event, to begin at 5:30 p.m., Sunday, Oct. 24, at Chicago s Palmer House Hilton. The South Africans -- one a lead
ARGONNE, Ill., Oct. 20 /PRNewswire/ -- A new biochip technology developed by American and Russian scientists may help stem the global resurgence of tuberculosis. The technology, developed by the U.S. Department of Energy s Argonne National Laboratory and the Russian Academy of Sciences Engelhardt Institute of Molecular
VIENNA, Va., Oct. 19 /PRNewswire/ -- CEL-SCI Corporation (Amex: HIV; Berlin Stock Exchange: LSR) announced today that independent investigators at AIDS ReSEARCH Alliance, West Hollywood, California, have completed a clinical study using CEL-SCI s Multikine(TM) to determine primarily its safety, and secondarily its abil
ST. LOUIS, Oct. 18 /PRNewswire/ -- Mallinckrodt Inc. (NYSE: MKG) announced today it has signed an agreement with Trimeris Inc. (Nasdaq: TRMS), Durham, N.C., to supply large-scale quantities of an investigational peptide, T-20, for use in continuing clinical trials for a novel therapeutic for the treatment of the human
LOS ANGELES, Oct. 15 /PRNewswire/ -- AIDS Project Los Angeles (APLA) supports the recent allocation of $8.7 million proposed by the Los Angeles Housing Department (LAHD) for the Housing Opportunities for Persons with AIDS (HOPWA) program. We are pleased that the City is moving forward and are hopeful that this proposal
ATLANTA, Oct. 14 /PRNewswire/ -- Biomedical Disposal, Inc. (Biomed) of Norcross received formal notification from California s Occupational Safety and Health Standards Board (Cal/OSHA) that use of advanced technology needle destruction units was authorized and encouraged as a method of compliance to that state s bloodb
ATLANTA, Oct. 14 /PRNewswire/ -- A regional conference that brings together experts from the public health sector, AIDS service organizations, and medical providers will convene in Atlanta to focus on HIV/AIDS in the African-American community. The conference is the fourth in a series of updates to the inaugural Nation
CARLSBAD, Calif., Oct. 14 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced the publication of data from a Multicenter AIDS Cohort Study in collaboration with the Institute of Human Virology and Johns Hopkins University examining immune response correlates of AIDS-free status in HIV-infecte
Regional Update Conferences on African-Americans and AIDS have been organized to focus on HIV/AIDS in the African-American community. What: Leading AIDS experts from the medical, research, government and public health sectors will address a wide range of issues relating to African-Americans and AIDS. Presentations at t
ATLANTA, Oct. 13 /PRNewswire/ -- Over 15,000 people in metro Atlanta are currently living with AIDS, and 11,347 Georgia area residents have died because of the disease since 1981. On Sunday, October 17th, thousands of Atlantans will gather at Piedmont Park to take part in the annual AIDS Walk Atlanta. Proceeds from the
MINNEAPOLIS, Oct. 13 /PRNewswire/ -- Chronimed Inc. (Nasdaq: CHMD), announced today that it has signed a contract with Visible Genetics Inc. (Nasdaq: VGIN) whereby Chronimed s wholly-owned subsidiary, Clinical Partners, will manage Visible Genetics prospective multi-center, controlled clinical trial of genotyping assis
WHAT: The National Association for the Advancement of Colored People (NAACP) will unveil an educational film series aimed at addressing the growing epidemic of HIV/AIDS in the African- American community. Developed in partnership with DuPont Pharmaceuticals and AT&T Broadband & Internet Services (AT&T BIS),
LOS ANGELES, Oct. 12 /PRNewswire/ -- AIDS Project Los Angeles (APLA) commends Governor Gray Davis for signing two important HIV/AIDS bills -- AB 155 and AB 136. AB 155 directly impacts the lives of people living with AIDS by assisting those who may be well enough to work, enter or reenter the workforce. AB 103 will all
BRISBANE, Calif., Oct. 12 /PRNewswire/ -- VaxGen , Inc. (Nasdaq: VXGN) today announced that it has inoculated more than 5,000 volunteers, completing enrollment in the United States portion of the North American trial of AIDSVAX(R), a vaccine designed to prevent infection by HIV. Additionally, the company announced it
PHILADELPHIA, Oct. 12 /PRNewswire/ -- Hemispherx Biopharma, Inc. (Amex: HEB; HEBws) today announced that it was developing clinical programs with Anderson Clinical Research that are designed to address the growing problem of multi-drug resistance found in battling the AIDS epidemic both in the U.S. and worldwide. The p
LOS ANGELES, Oct. 11 /PRNewswire/ -- As more women become infected with HIV and as it becomes more important to test new treatments on women, a pilot project suggests that targeted outreach and service techniques dramatically increase the enrollment and retention of women participating in HIV-related clinical trials. T
SAN FRANCISCO, Oct. 11 /PRNewswire/ -- A new HIV/AIDS database being developed at UC San Francisco is designed to serve as a centralized location for real-world treatment outcomes and as a resource for the international medical community in treating HIV disease. The system is named HIVWatch. The UCSF Positive Health Pr
LOS ANGELES, Oct. 11 /PRNewswire/ -- Details of the largest clinical trial to closely determine sex differences in HIV treatment were presented today at the 1999 National Conference on Women and HIV/AIDS, being held at the Los Angeles Convention Center. The A.T. L.A.S.T. (Antiretroviral Trial Looking at Sex and Treatme
SAN MATEO, Calif., Oct. 7 /PRNewswire/ -- SciClone Pharmaceuticals (Nasdaq: SCLN), today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for the Company s second U.S. patent covering the use of its lead drug, ZADAXIN, to treat hepatitis C. ZADAXIN boosts the immune system in the fig
WASHINGTON, Oct. 8 /PRNewswire/ -- A $1,500 cap on outpatient therapy hinders access to much needed rehabilitation treatment by Medicare beneficiaries according to testimony made by the American Speech-Language- Hearing Association (ASHA) on October 1, 1999. Speaking before the Subcommittee on Health of the House Ways
NEW YORK, Oct. 8 /PRNewswire/ -- After surveying 100 HIV specialists in North America, Latin America and Europe, Datamonitor found that Sustiva and Combivir were rated as the best new drugs to address patient compliance. The survey also revealed that specialists rate patient compliance as
SPRING VALLEY, N.Y., Oct. 8 /PRNewswire/ -- Par Pharmaceutical, a wholly owned subsidiary of Pharmaceutical Resources, Inc. ( PRI ) (NYSE: PRX; PCX), has filed an abbreviated new drug application (ANDA) for megestrol acetate oral suspension with the FDA . Par believes that it was the first company to have its ANDA acce
Regional Update Conferences on African-Americans and AIDS have been organized to focus on HIV/AIDS in the African-American community. What: Leading AIDS experts from the medical, research, government and public health sectors will address a wide range of issues relating to African-Americans and AIDS. Presentations at t
CHICAGO, Oct. 8 /PRNewswire/ -- The AIDS Memorial Quilt is going to the 1999 Parliament of the World s Religions in Cape Town, South Africa , the first week of December. The largest Quilt display ever taken to South Africa, more than 1,000 panels naming those who have died from the disease, will be presented on the Par
DURHAM, N.C., Oct. 7 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) today announced the modification of its clinical Study MKC-303 relating to Coactinon(R) (emivirine), formerly known as MKC-442. All patients will be offered the opportunity to stay on Coactinon with or without nelfinavir, or change to a
PRNewswire - OAKLAND, Calif., Oct. 6 /PRNewswire/ -- It was October 17, 1989 and Project Open Hand was set to start delivering Meals with Love to People with AIDS in Alameda County. The organization had already been providing nutritious, home delivered meals in San Francisco for four years and was furthering its reach
WASHINGTON, Oct. 6 /PRNewswire/ -- The United Nations Children s Fund (UNICEF) is turning its back on the truth by pushing sex education programs on the youth of Kenya , said Mark DeYoung, director of Why Life? Isn t it about time we learn from the mistakes of the past? These programs are doomed for failure. There is n
NEW YORK, Oct. 6 /PRNewswire/ -- To reduce the spread of HIV around the globe, leading researchers and health experts at a symposium sponsored by the American Foundation for AIDS Research (amfAR) have urged the development of gels and other natural substances that women can use to block HIV transmission. Called microbi
CAMBRIDGE, Mass., Oct. 6 /PRNewswire/ -- All fruits and vegetables are not created equal. That s what a recent Harvard University study published in the October 6 issue of the Journal of the American Medical Association (JAMA) confirms. Researchers at Brigham and Women s Hospital (BWH) and Harvard School of Public Heal
BETHESDA, Md., Oct. 5 /PRNewswire/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today reported that its product, PRO 140, possesses potent and broad-spectrum anti-HIV activity. PRO 140 is a promising new compound that inhibits HIV entry via a novel mechanism. These findings, from a preclinical study carried out in
CHICAGO, Oct. 4 /PRNewswire/ -- Correctional health officials from 17 of the nation s jails are meeting in Chicago, with their public health counterparts, in a landmark meeting to address the growing health emergency in prisons created by HIV/AIDS and other infectious diseases. During the meeting Rev. Jesse Jackson, Sr
CHICAGO, Oct. 4 /PRNewswire/ -- The female condom is now positioned to play a critical role in winning the global war on AIDS, Mary Ann Leeper, Ph.D., president of the U.S.-based Female Health Company (OTC Bulletin Board: FHCO), announced at the recent International Conference on AIDS and STDs in Africa (ICASA). The Se
BELTSVILLE, Md., Oct. 1 /PRNewswire/ -- Digene Corporation (Nasdaq: DIGE) announced today that a government report in the United Kingdom , published today by the Imperial Cancer Research Fund, has backed testing for human papillomavirus (HPV), the cause of cervical cancer, as part of the National Cervical Screening Pro
LAVAL, Quebec, Canada , Oct. 1st /CNW-PRN/ - BioChem Pharma Inc. (NASDAQ: BCHE; ME, TSE: BCH) announces the launch of Heptodin (lamivudine), the world s first oral antiviral treatment for chronic hepatitis B, in China , which has the highest prevalence of the disease in the world. Heptodin, known as Zeffix in most cou
NEW YORK, Oct. 1 /PRNewswire/ -- Thousands of people living with HIV/AIDS use complementary and alternative medicines (CAM) every day to enhance their health. Treatments range from vitamins, to herbs to yoga and acupuncture. But are CAM treatments safe and effective to use with the complicated pharmaceutical regimens t
CHICAGO, Sept. 30 /PRNewswire/ -- Promoting good oral health and total wellness are key goals of the American Dental Hygienists Association (ADHA) as evidenced by its long-time sponsorship of National Dental Hygiene Month (NDHM) in October. This year, ADHA will add participation in the LaSalle Banks Chicago 5K Marathon
WASHINGTON, Sept. 30 /PRNewswire/ -- Over the next year, the American Red Cross will implement a plan to accelerate to a full conversion of fresh frozen plasma to its virus-inactivated alternative, PLAS+(R)SD (Pooled Plasma, Solvent Detergent Treated). Consistent with this conversion policy, the American Red Cross will
WASHINGTON, Sept. 30 /PRNewswire/ -- In October, millions of women will have access to specialized information about the proper use of medications in a national public awareness campaign being jointly conducted by the U.S. Food and Drug Administration ( FDA ) and the National Association of Chain Drug Stores. An un
ARLINGTON, Va., Sept. 30 /PRNewswire/ -- To increase the level of educational and therapeutic support it provides to members of the hemophilia community around the world, the American Red Cross has launched an initiative called the American Red Cross CARE 2000(TM), a multi-million dollar initiative that is the first in
WHEELING, Ill., Sept. 30 /PRNewswire/ -- Dedicated to helping children, VTech, the leading manufacturer of electronic learning toys, has teamed up with Pediatric AIDS Chicago, a non-profit group that supports national pediatric AIDS research, education and hands-on care-giving organizations, to raise money through the
CAMBRIDGE, Mass., Sept. 30 /PRNewswire/ -- Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Kissei Pharmaceutical Co., Ltd. (Matsumoto-City, Japan ) announced today that Kissei is launching Prozei(TM) ( amprenavir ), an orally administered HIV protease inhibitor, in Japan.
WHAT: The United States Conference on AIDS, the largest HIV/AIDS meeting in the US, will convene more than 3,000 community-based workers, people living with HIV, physicians, social workers, health department officials, policy makers, funders and community activists from around the nation for four days of learning, shar
LOS ANGELES, Sept. 29 /PRNewswire/ -- A broad coalition of state and local representatives of the disabled community urged Governor Davis to sign AB 155 (Migden), which will allow disabled individuals to return to work and maintain their health care benefits through the Medi-Cal program. The advancement in medical trea
LOS ANGELES, Sept. 29 /PRNewswire/ -- In a victory for AIDS patients and care providers throughout California, Governor Gray Davis signed AB 1047 (Marco Firebaugh D Cudahy), a bill that will improve access to potentially life-saving AIDS drugs for many low and moderate income Californians. The bill, one of two AIDS Hea
SAN FRANCISCO, Sept. 29 /PRNewswire/ -- The results of a multicenter Phase III study comparing the efficacy and safety of gatifloxacin to clarithromycin in treating community-acquired pneumonia (CAP) showed gatifloxacin to be more effective. The study findings were presented this week at the 39th Interscience Conferenc
SAN FRANCISCO, Sept. 29 /PRNewswire/ -- Data from a virology sub-study of the DuPont Pharmaceuticals Sustiva (TM) (efavirenz) Expanded Access Program indicate that 78 percent of patients who initiate combination therapy with Viramune (R) (
CARLSBAD, Calif., COLLEGEVILLE, Pa. and ANTONY, France , Sept. 29 /PRNewswire/ -- Isis Pharmaceuticals (Nasdaq: ISIP) and Rhone-Poulenc Rorer (NYSE: RP) (RPR) announced today that they have signed a three year collaboration to assess genes identified within RPR s genomics programs using Isis Antisense Ta
SAN FRANCISCO, Sept. 28 /PRNewswire/ -- Results of a new phase II study with Agenerase ( amprenavir )+ Ziagen ( abacavir sulfate) during the early stage of HIV infection focu
SAN FRANCISCO, Sept. 28 /PRNewswire/ -- Results of two French studies that focus on simplifying HIV/AIDS treatment regimens were presented today at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) meeting by Professor Francois Raffi, a researcher at the Centre Hospitalier Regional et Un
SAN FRANCISCO, Sept. 28 /PRNewswire/ -- Data presented today at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy describe anti-viral activity of DuPont Pharmaceuticals Sustiva (TM)( efavirenz ) in patients with high viral load (greater than or equal to 100,000 copies/mL
DEERFIELD, Ill, Sept. 28 /PRNewswire/ -- Fujisawa Healthcare, Inc. (Fujisawa) today announced the results of clinical trials for FK463, a systemic antifungal agent of the echinocandin class. Study results concluded that, in an AIDS population, FK463 was effective in improving or clearing clinical signs and symptoms of
MOUNTAIN VIEW, Calif., Sept. 28 /PRNewswire/ -- Of the 40,00 people infected with HIV in the U.S. each year, certain groups, such as ethnic minorities, women, and IV drug users, are often overlooked in awareness and treatment programs. Pharmaceutical companies that target these untapped populations with treatment educa
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- SUGEN, Inc. today presented positive data from a dose-escalating Phase I trial of SU5416, its lead angiogenesis inhibitor, in AIDS-related Kaposi s sarcoma (KS), at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), in San Francisco, CA. Results fr
ABBOTT PARK, Ill., Sept. 27 /PRNewswire/ -- Data from two Phase 2 studies presented today at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco suggest Abbott Laboratories (NYSE: ABT) investigational protease inhibitor, ABT-378/ ritonavir (ABT-378/r), d
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Early data reported for the first time today suggest that VX-175/GW433908, the prodrug of the HIV protease inhibitor amprenavir , is a candidate for further clinical evaluation. Three reports on VX-175/GW433908 covering the design of the compound, preclinical and early clinical s
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- DuPont Pharmaceuticals today, as part of the company s commitment to find new drugs with superior potency against HIV infections, presented data from pre-clinical studies on four second-generation non-nucleoside reverse transcriptase inhibitors (NNRTIs) currently in simultaneous
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Today researchers unveiled 48-week data from the Atlantic Study, the first trial to directly compare the effect of the three different available classes of AIDS drugs within combination regimens. Preliminary results from this ongoing multi-center international trial show that tri
LOS ANGELES, Sept. 27 /PRNewswire/ -- Clinical and social science researchers have found that there are many reasons for the increase in the number of reported HIV/AIDS cases among women, especially women of color. The reasons range from social to economical, behavioral to biological factors. While the mortality rate a
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- A late breaker study presented today at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) by Dr. Michael Saag of the University of Alabama, Birmingham found that phenotypic HIV drug resistance testing is superior to treatment history in predicting
DURHAM, N.C., Sept. 27 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced today that it will present promising resistance profile data on Coactinon(R) (emivirine), formerly known as MKC-442, from a laboratory study of HIV-1 mutations and sensitivity to other antivirals in HIV-infected patients who
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Hoffmann-La Roche Inc. today announced preliminary study results demonstrating the safety of Tamiflu (oseltamivir phosphate) in elderly and high-risk patients, as well as data that shows the efficacy and safety benefit of Tamiflu in the long-term prevention of influenza in elderl
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Forty-eight week results from a study comparing Agenerase (TM) ( amprenavir )+ Epivir (R) (lamivudine)+Retrovir(R) (zidovudine) to a placebo+Epivir+Retrovir were presented today at the 39th Intersc
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- In vitro data from a study analyzing rates of antiviral resistance to the five currently approved protease inhibitors , including Agenerase ( amprenavir ), among heavily pre- treated patients with HIV wer
DEERFIELD, Ill. and FOSTER CITY, Calif., Sept. 27 /PRNewswire/ -- Fujisawa Healthcare, Inc. (Fujisawa) and Gilead Sciences , Inc. (Nasdaq: GILD) today presented results from a Phase III clinical study comparing the safety and efficacy of AmBisome (liposomal amphotericin B) to conventional amphotericin B for the initial
LA JOLLA, Calif., Sept. 27 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. and The Immune Response Corporation (Nasdaq: IMNR) today announced that a pivotal trial has been initiated to further evaluate the safety and efficacy of REMUNE(TM) (HIV-1 Immunogen), in combination with highly active antiretroviral therapy (HAART
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- A new pharmacokinetic study of once-daily Crixivan (R) ( indinavir sulfate) combined with another protease inhibitor, ritonavir(A), showed that blood levels of Crixivan were boosted to levels that were comparable to those seen in a prior study with the app
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) presented results of a Phase I clinical trial in which PRO 542, a novel inhibitor of HIV entry, was shown to have antiviral activity. The results were reported Sunday at the 39th Interscience Conference on Antimicrobial Agents and Ch
DURHAM, N.C., Sept. 27 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced that it presented preliminary data yesterday on the pharmacokinetics and tolerability of Coactinon(R) (emivirine), formerly known as MKC-442, in HIV-1 infected pregnant women and their offspring. Coactinon, Triangle s most ad
DURHAM, N.C., Sept. 27 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS) announced that it will be presenting preclinical data today on in vitro activity of DAPD against drug-resistant strains of HIV at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. Based
SAN FRANCISCO, Sept. 27 /PRNewswire/ -- Applying a US Food and Drug Administration ( FDA )-endorsed new standard of data analysis in HIV that measures duration of treatment response, DuPont Pharmaceuticals today released the latest findings on Sustiva (TM) (
SAN FRANCISCO, Sept. 26 /PRNewswire/ -- Forty-eight week results from a study comparing Agenerase (TM) ( amprenavir )+ Epivir (R) (lamivudine)+ Retrovir(R) (zidovudine) to a placebo+Epivir+Retrovir were presented today at the 39th Inters
SAN FRANCISCO, Calif., Sept. 26 /PRNewswire/ -- Data presented today demonstrate that a once-daily (QD) dose of the protease inhibitor FORTOVASE(R) (saquinavir) in combination with a mini-dose of the protease inhibitor ritonavir significantly increases the blood level of FORTOVASE above the level currently believed to
SAN FRANCISCO, Sept. 26 /PRNewswire/ -- Forty-eight week data from a study comparing the triple nucleoside reverse transcriptase inhibitor (NRTI) regimen of Ziagen (abacavir sulfate)+ Combivir (lamivudine/zidovudine) to treatment with Cr
SAN FRANCISCO, Sept. 26 /PRNewswire/ -- In vitro data from a study analyzing rates of viral resistance to the five currently approved protease inhibitors , including Agenerase ( amprenavir ), among heavily pre-treated patients with HIV were pre
SAN FRANCISCO, Sept. 26 /PRNewswire/ -- Applying a US Food and Drug Administration ( FDA )-endorsed new standard of data analysis in HIV that measures duration of treatment response, DuPont Pharmaceuticals today released the latest findings on Sustiva (TM) (
LAVAL, Quebec, Canada , Sept 26 /CNW - PRN/ - BioChem Pharma Inc. (NASDAQ: BCHE; ME, TSE: BCH) announced today that several of the Company s development or research initiatives will be the subject of oral or poster presentations at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) taking
SOUTH SAN FRANCISCO, Calif., Sept. 26 /PRNewswire/ -- ViroLogic, Inc. s novel phenotypic HIV drug resistance assay, PhenoSense(TM) HIV, will be the subject of seven studies to be presented at the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 26-29. Included am
LOS ANGELES, Sept. 23 /PRNewswire/ -- In a letter sent to all presidential candidates, organizers of the 1999 National Conference on Women and HIV/AIDS (October 9-12, 1999) invited candidates to answer several questions related to social, policy, program, and research funding for HIV/AIDS issues among women. Ferd Eggan
PHILADELPHIA, Sept. 23 /PRNewswire/ -- Adolescents infected with HIV were found to have a surprisingly high number of certain immune system cells, according to a research team led by an immunologist at The Children s Hospital of Philadelphia. In studying 94 HIV-positive patients, aged 13 to 19, the researchers found a
EVANSTON, Ill., Sept. 23 /PRNewswire/ -- Immtech International Inc., (Nasdaq: IMMT) today announced that it will be entering into Phase I clinical trials in first quarter of 2000 with DAP-092 for the treatment of Cryptosporidium and Giardia parasitical infections. DAP-092 is designed to treat severe diarrhea and wastin
FOSTER CITY, Calif., Sept. 23 /PRNewswire/ -- Worldwide sales for the gene therapy market is expected to reach a total of $4.8 million by 2008. Gene therapy products in development primarily target cancer, with a lower emphasis on HIV, cardiovascular, cystic fibrosis, hemophilia A and Gaucher s disease. Future trends i
SOUTH SAN FRANCISCO, Calif., Sept. 22 /PRNewswire/ -- Up to 28% of newly infected individuals may contract HIV that is resistant to one or more anti-AIDS drugs, according to two studies published today in the Journal of the American Medical Association . The studies were carried out by various medical research institut
CHADDS FORD, Pa., Sept. 22 /PRNewswire/ -- Starting today, a new patch medication to treat the chronic nerve pain often experienced after a case of shingles will be available in pharmacies nationwide, according to product marketer Endo Pharmaceuticals, Inc. of Chadds Ford, Pennsylvania. (Photo: NewsCom: http://www.news
NEW YORK, Sept. 22 /PRNewswire/ -- Just in time for National Condom Month (October), industry leader Trojan(R) brand condoms is hitting the shelves with one of the most significant advances in the condom industry since the development of latex in the 1930s -- new Trojan Supra(TM) Microsheer(TM) Polyurethane condoms. T
TORONTO, Sept. 20 /PRNewswire/ -- Visible Genetics Inc. (VGI) (Nasdaq: VGIN) reported today that on Friday the U.S. Food and Drug Administration s ( FDA ) Blood Products Advisory Committee (BPAC) recommended the reclassification of all HIV genotyping drug resistance assays from Class III to Class II with special contro
NEW YORK, Sept. 17 /PRNewswire/ -- Playboy Enterprises announced today that it would host an exclusive cocktail supper to benefit the New York based AIDS research organization, Community Research Initiative on AIDS (CRIA). The September 22nd dinner will celebrate Playboy s participation in Sotheby s Fashion department
NEW HAVEN, Conn., Sept. 17 /PRNewswire/ -- The Boston to New York AIDS Ride 5 Presented By Tanqueray, which was cancelled yesterday for the first day of the three-day bicycling trek because of Hurricane Floyd, will continue today for a portion of the route. Over 2,550 Riders who raised $7 million for AIDS services in B
WASHINGTON, Sept. 17 /PRNewswire/ -- The Constituency for Africa (CFA) and the Ronald H. Brown Foundation today honored Congresswoman Barbara Lee (D-CA) and Bristol-Myers Squibb Company in recognition of two historic African AIDS/HIV initiatives. Rep. Lee was honored for introducing legislation to fund the AIDS Marshal
The Constituency for Africa (CFA) and the Ronald H. Brown Foundation Laud Marshall Plan for Africa Legislative Initiative and Secure the Future Program with its Constituent of the Year Award WHAT: The Constituency for Africa (CFA) and the Ronald H. Brown Foundation will honor Congresswoman Barbara Lee (D-CA) and
Reverend Dr. Calvin 0. Butts, III, Senior Pastor of the Abyssinian Baptist Church, will undergo screening tests for multiple chronic diseases -- ranging from high blood pressure to HIV/AIDS -- as a demonstration of his personal support for this week s Harlem Health Expo, a free public health education program sponsored
FOSTER CITY, Calif., Sept. 15 /PRNewswire/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today announced that the company has reacquired product rights to its AIDS gene therapy program following the termination of a collaboration agreement with Hoechst Marion Roussel, Inc. The agreement has provided funding for Cell Genesys AID
NEW YORK, Sept. 15 /PRNewswire/ -- The National Black Leadership Commission on AIDS (BLCA) today launched Break the Silence, a major public health initiative designed to raise awareness of HIV/AIDS and to promote HIV prevention, testing and treatment in the African-American community. The Health Expo, a free educationa
LOS ANGELES, Sept. 10 /PRNewswire/ -- AIDS Project Los Angeles (APLA) applauds the California State Legislature for passing AB 155, AB 103 and AB 136, three important HIV/AIDS bills, and urges Governor Gray Davis to expeditiously sign the bills into law. APLA, on its own and in collaboration with various other organiza
BELTSVILLE, Md., Sept. 10 /PRNewswire/ -- A paper published today in the British Journal of Cancer shows that testing for the human papillomavirus (HPV), the virus that causes cervical cancer, is a more accurate method than the Pap smear for identifying women with cervical disease. The study, conducted by the Imperial
FERNDALE, Mich., Sept. 9 /PRNewswire/ -- More than 100 of Detroit s most prominent artists will donate pieces of original art to be auctioned at the fourth annual ART WORKS FOR LIFE AIDS benefit. This exciting event will begin at 6:30 p.m. on Saturday, September 18, 1999 at the Edsel and Eleanor Ford House in Grosse Po
AMERSTERDAM, the Netherlands , Sept. 9 /PRNewswire/ -- Chiron Corporation (Nasdaq: CHIR) today announced that the French Ministry of Health (AFSSAPS) has granted an Authorization for Temporary Use (ATU) of Macrolin* IL-2 for the treatment of people with advanced HIV infection, who despite effective anti-retroviral trea
WASHINGTON, Sept. 8 /PRNewswire/ -- The recent stavudine ( d4T or Zerit ) and didanosine (ddI or Videx ) approval by the Food and Drug Administration is good news for patients and their doctors according to the National Association of
MONTREAL, Sept. 7 /PRNewswire/ -- At 8:30 a.m. on Sunday, September 5 at the Hotel du Parc, Montreal, at the Conference of Global Strategies for the Prevention of HIV Transmission from Mothers to Children, a French Countess who devotes her time and fortune to saving children orphaned by AIDS, will call upon the world s
MINNEAPOLIS, Sept. 7 /PRNewswire/ -- In a continuation of efforts to improve drug therapies for HIV, Hughes Institute scientists report the development of a series of drugs which show remarkable activity against all HIV strains tested. The results of this research, reported in this month s issue of Antiviral Chemistry
SOUTH SAN FRANCISCO, Calif., Sept. 7 /PRNewswire/ -- Phenotypic HIV drug susceptibility testing can provide an early warning of HIV drug resistance before combination drug therapy fails, according to a clinical research article published in the September issue of the Journal of Infectious Diseases (http://www.journals.
According to 1998 New York State Department of Health data, African-Americans accounted for 51% of all reported AIDS cases in the city of New York even though they only make up 25% of the city s population. Why does the HIV/AIDS epidemic affect the African-American community at such an alarming rate? Come join the Nati
Regional Update Conferences on African-Americans and AIDS have been organized to focus on HIV/AIDS in the African-American community. WHAT: Leading AIDS experts from the medical, research, government and public health sectors will address a wide range of issues relating to African-Americans and AIDS. Presentations at t
CARLSBAD, Calif., Sept. 7 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced that data from two U.S. Remune(TM) trials appeared in the September issue of the peer-reviewed scientific publication, The Journal of Infectious Diseases, Vol. 180(3), 1999. The preliminary results of a Phase 1 stud
COLUMBUS, Ohio, Sept. 3 -- The technology exists to protect registered nurses and other health care workers from deadly needlestick injuries, yet less than 15 percent of U.S. hospitals use safe needle devices -- putting health care workers at risk for contracting life-threatening infections such as HIV and Hepatitis C.
LOS ANGELES, Sept. 3 -- AIDS activists expressed dismay and anger at California State Assembly Member Carole Migden (D, San Francisco) for her failure to use her leadership on the Assembly Appropriations Committee to help pass SB 1258. The measure, by State Senator Richard Polanco (D, Los Angeles), would have directed
JOHANNESBURG, South Africa and NEW YORK, Sept. 3 -- Bristol-Myers Squibb Company (NYSE: BMY) and the Government of South Africa today announced that Bristol-Myers Squibb is joining the South African Partnership Against AIDS and will collaborate with the Department of Health to achieve the goals of the Secure The Future
NEW YORK, Sept. 3 /PRNewswire/ -- Jules Levin, the Executive Director of the National AIDS treatment Advocacy Project, is the host/producer for a new concept in talk radio. Every Sunday night from 11 PM to 12 Midnight Jules will host Living Well With HIV, a talk interview show on current HIV and hepatitis treatment iss
NEW YORK, Sept. 2 -- The second international conference on global strategies for the prevention of HIV transmission from mothers to infants is being held in Montreal, Canada . This information is provided by The American Foundation for AIDS Research (amfAR). (Video: http://www.prnewswire.com/orbis/2848/jump_public.htm
PRINCETON, N.J., Sept. 2 -- The Liposome Company, Inc. (Nasdaq: LIPO) today announced that it has received marketing approval for its 50-milligram ABELCET(R) (Amphotericin B Lipid Complex Injection) vial from the Food and Drug Administration. The 50-milligram vial will also be available in the
LOS ANGELES, Sept. 1 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation has signed on to the Call to Action issued today at the Montreal meeting Global Strategies for the Prevention of HIV Transmission from Mothers to Infants. To demonstrate its support, the Foundation committed $1 million to mobilize a wor
MONTREAL, Sept. 1 /PRNewswire/ -- If prevention methods are implemented immediately, more than one million additional HIV infant infections can be prevented by 2003, predicted researchers today at the second Global Strategies for the Prevention of HIV Transmission from Mothers to Infants conference opening in Montreal
MEMPHIS, Tenn., Aug. 30 /PRNewswire/ -- The gene MRP4 appears to help T cells, key components of the human immune system, pump out certain anti-HIV drugs and may allow the development of drug-resistant strains of HIV, report a team of St. Jude Children s Research Hospital scientists in the September issue of Nature Med
CHICAGO, Aug. 27 /PRNewswire/ -- The Female Health Company (OTC Bulletin Board: FHCO) today announced it has been awarded a significant contract for the purchase of 2 million female condoms from the Brazilian Ministry of Health. The order is part of the Brazilian government s national AIDS prevention program supported
WHAT: The developed world has experienced a decline in mother-to-child HIV transmission with fewer than 300 infants born every year with HIV in the U.S., however, rates of mother-to-child infection in the developing world including India , China and Africa continue to rise. Worldwide, more than 1,600 infants a day are
LOS ANGELES, Aug. 24 /PRNewswire/ -- AIDS Project Los Angeles (APLA) applauds the State Senate on its passage of Assembly Bill 518, legislation that will allow local communities to enact clean needle and syringe exchange projects as part of a network of comprehensive HIV services for injection drug users. Injection dru
DALLAS, Aug. 24 /PRNewswire/ -- The HIV epidemic has created business opportunities for many people. In many cases, people and companies pursue these opportunities with the sincere intention of helping while staying within the bounds of the law and maintaining fiscal integrity. The same motives can sometimes lead to ha
PRINCETON, N.J., Aug. 24 /PRNewswire/ -- The Liposome Company, Inc. (Nasdaq: LIPO) today announced that it has received regulatory approval for ABELCET(R) (Amphotericin B Lipid Complex Injection) from the Ministry of Health in Belgium . The indication for ABELCET(R) is for the treatment of invasive fungal infections in
TALLAHASSEE, Fla., Aug. 23 /PRNewswire/ -- State Treasurer and Insurance Commissioner Bill Nelson today charged deception and misrepresentation by a South Florida firm dealing in viatical products, which is the sale-and-resale of life insurance policies, usually of the terminally ill. In an order issued today, Nelson g
Despite the scientific advances, the spread of injection drug use and the resultant increase in HIV transmission continue. Worldwide, 129 countries and territories now report injecting drug use, with 109 countries reporting HIV or AIDS in the drug-using population. The collective evidence presented at the 1998 Global R
LOS ANGELES, Aug. 19 /PRNewswire/ -- Rep. Nancy Pelosi (D-CA) and 20 other members of California s Congressional delegation today sent Governor Gray Davis a letter urging him to support AB 518, the state legislation introduced by Assembly Member Kerry Mazzoni, that would allow local governments in California to establi
ATLANTA, Aug. 20 /PRNewswire/ -- More than 2,000 leading scientists, researchers and policy analysts will gather at the Hyatt Regency hotel in Atlanta for the National HIV Prevention Conference, the first meeting of its kind exclusively devoted to scientific efforts to monitor and prevent HIV in the US. The conference
CHICAGO, Aug. 20 /PRNewswire/ -- New protease inhibitors that can treat HIV patients are currently being tested around the world and Rush-Presbyterian-St. Luke s Medical Center in Chicago is one of 16 medical centers in the country participating in a new study that doctors hope will continue the string of successes dru
MELVILLE, N.Y., Aug. 12 /PRNewswire/ -- V. I. Technologies, Inc. (Nasdaq: VITX) announced today that the Company has filed an Investigational New Drug (IND) amendment with the U.S. Food and Drug Administration ( FDA ) to commence trials of a new version of PLAS+SD which removes the antibodies that cause plasma to be bl
EMERYVILLE, Calif., Aug. 18 /PRNewswire/ -- Chiron Corporation (Nasdaq: CHIR) announced today that it is enrolling patients in its international Phase III study, called SILCAAT, evaluating the safety and effectiveness of Proleukin(R) (aldesleukin) Interleukin-2 in combination with standard anti-HIV therapy in people li
HOLLYWOOD, Calif., Aug. 17 /PRNewswire/ -- FRASIER, the sophisticated Emmy Award-winning series from Grub Street Productions in association with Paramount Network Television, begins production this week on its seventh season for NBC-TV. FRASIER, which made history with its record-breaking five consecutive Emmy Awards f
SAN FRANCISCO, Aug. 11 /PRNewswire/ -- One Business Team (1BT.com), a leading e-commerce provider of office products and services exclusively for small-to-medium sized businesses, today announced that they will be one of the sponsors of Until There s A Cure Day at 3Com Park on Sunday, August 15th, a day devoted to find
NEW YORK, Aug. 16 /PRNewswire/ -- Every Sunday August 22 on WOR Radio 710 in NYC at 11 PM to 12 Midnight, Living Well with HIV will be on the air. Its a new concept in talk radio. The focus will be in-depth discussions of HIV and hepatitis treatment issues. Each week will be a new cutting edge topic and will have a lea
CARLSBAD, Calif., Aug. 12 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR) today announced its Latin American corporate partner, Roemmers Laboratory (formerly Viru-Tech), is conducting a REMUNE(TM) Phase 2 clinical trial in South America. This 28-week clinical trial is being conducted by GEMA (Grupo de Es
LOS ANGELES, Aug. 11 /PRNewswire/ -- The State of Florida s Agency for Health Care Administration (AHCA) has contracted with Los Angeles-based AIDS Healthcare Foundation (AHF) to create a new disease management program for 7,500 Medicaid recipients who are afflicted with the AIDS virus. The program, called Positive Hea
SANTA FE, N.M., Aug. 10 /PRNewswire/ -- Thermo BioAnalysis Corporation (Amex: TBA), a Thermo Electron company, today announced that its BioStar, Inc. subsidiary has agreed with CooperSurgical, Inc. (CSI) to co-market, on a non- exclusive basis, three physician-office diagnostic tests for vaginitis, a condition that res
REDWOOD CITY, Calif. and SAN FRANCISCO, Aug. 10 /PRNewswire/ -- Excite@Home (Nasdaq: ATHM) today announced that it will create an interactive entertainment site for this year s Macy s Passport 99 Extreme event series, marking the first time an Internet portal is sponsoring and hosting an online presence for the interna
ABBOTT PARK, Ill., Aug. 10 /PRNewswire/ -- Abbott Laboratories (NYSE: ABT) today announced that the European Union s Committee for Proprietary Medicinal Products (CPMP) has adopted a positive opinion on Norvir (R) ( ritonavir ) soft capsules.
SANTA MONICA, Calif., Aug. 10 /PRNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation greeted with pleasure the August 11 publication of a new study by the Centers for Disease Control and Prevention on sharp reductions in the number of pediatric AIDS cases in the U.S. This is great progress. We ve worked toward
LAVAL, Quebec, Canada , August 6 /CNW-PRN/ - BioChem Pharma Inc. (NASDAQ: BCHE; Montreal Exchange and The Toronto Stock Exchange: BCH) announced today that the Opposition Division of the Australian Patent Office (APO) rejected Emory University s patent application (APO 658136) relating to
RED BANK, N.J., Aug. 5 /PRNewswire/ -- LifeStyles(R) condoms is launching its new advertising campaign linking one of the nation s favorite passions -- sports -- with one of its oldest themes -- sexual frustration. The new LifeStyles ad campaign line, Haven t gotten any lately? with its image of blue colored athletic b
LOS ANGELES, Aug. 4 /PRNewswire/ -- In a press conference at AIDS Healthcare Foundation s (AHF s) Hollywood headquarters, AIDS and homeless activists led by AHF president Michael Weinstein today announced the filing of an additional lawsuit against the City of Los Angeles over the City s gross mismanagement of the city
WASHINGTON, Aug. 4 /PRNewswire/ -- Testifying today before the House Commerce Committee s Subcommittee on Health and the Environment, AAHP President & CEO Karen Ignagni called on Congress to act this year to address the crisis in the Medicare+Choice program and preserve choices and important benefits -- including p
WAYNE, Pa., Aug. 4 /PRNewswire/ -- The editors at 4anything.com, having worked in secrecy, today declassified the location where curiosity seekers can find the best resources for the most famous, compelling and beguiling obsessions of the century -- 4ConspiracyTheories.com. The site where Just because you re paranoid d
NEW YORK, Aug. 4 /PRNewswire/ -- Every Sunday night at 11 PM to 12 Midnight on WOR Jules Levin hosts Living Well With HIV. A new concept in talk radio. The show explores a different topic every week with a guest researcher. This Sunday the guests include Dr Fred Valentine, an immunologist an NYU/Bellevue Medical Center
CARLSBAD, Calif., Aug. 4 /PRNewswire/ -- Vitravene(TM), the antiviral drug developed by Isis Pharmaceuticals (Nasdaq: ISIP) and marketed by CIBAVision, has been approved by European regulatory authorities. Isis and CIBAVision Corporation, the eye care unit of Novartis AG, a leading world sciences company have been info
KING OF PRUSSIA, Pa. and POWELL, Ohio, Aug. 4 /PRNewswire/ -- TeleSpectrum Worldwide Inc. (Nasdaq: TLSP) announced today they have agreed to establish a long-term strategic alliance with Drug Emporium, Inc. s (Nasdaq: DEMP) online venture, DrugEmporium.com. The new on-line store, which will be re-launched in August, wi
MOUNTAIN VIEW, Calif., Aug. 4 /PRNewswire/ -- SGI (NYSE: SGI) today announced that the National Cancer Institute (NCI) will acquire a Cray SV1(TM) supercomputer to help NCI scientists accelerate research into the causes and treatments for life-threatening diseases such as cancer, AIDS and Alzheimer s disease. NCI chose
LOS ANGELES, Aug. 3 /PRNewswire/ -- A regional conference that brings together experts from the public health sector, AIDS service organizations, and medical providers who provide care for African-Americans will convene in Los Angeles tomorrow to focus on HIV/AIDS in the African-American community. The conference is th
CHICAGO, Aug. 2 /PRNewswire/ -- The Female Health Company (OTC Bulletin Board: FHCO) today announced that it received an order from the Province of Mpumalanga in South Africa for 900,000 Female Condoms. Mpumalanga, one of 9 provinces in South Africa, has a population of approximately 3 million people. According to
FOSTER CITY, Calif., July 29 /PRNewswire/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today reported that the company has developed a third-generation lentiviral gene delivery system with an improved safety profile for patients with hemophilia and other patients at risk for human immunodeficiency virus (HIV) infection. In a n
WARWICK, R.I., July 28 /PRNewswire/ -- Calling for a policy shift across the international development community, Childreach announced an innovative approach to the fast growing number of children orphaned by AIDS, a problem it believes is the greatest risk to the future of Africa. Humanitarian groups currently emphasi
Regional Update Conferences on African-Americans and AIDS have been organized to focus on HIV/AIDS in the African-American community. What: Leading AIDS experts from the medical, research, government and public health sectors will address a wide range of issues relating to African-Americans and AIDS. Presentations at t
CHICAGO, July 26 /PRNewswire/ -- AWARE Talk Radio, the nation s first, weekly syndicated radio program tackling sexual health, HIV and well-being issues starts weekly broadcasts in metropolitan New York City on WWRL 1600 AM (100% Pure Soul) on Monday, August 2nd at 2 p.m. with a special broadcast entitled: Lipodystroph
TARRYTOWN, N.Y., July 21 /PRNewswire/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX - news) announced that it has received two new awards from the National Institutes of Health (NIH) for the development of novel HIV therapies and vaccines. The first award was granted to Progenics under Phase II of the Small Business
LYON, France , July 13 /PRNewswire/ -- Preliminary findings from the largest Phase II trial ever to be conducted with a candidate vaccine against the AIDS virus, HIV, shows that an HIV vaccine induces immune responses. The findings were presented today by Dr. Robert Belshe, of Saint-Louis University during the Internat
WEST HOLLYWOOD, Calif., July 9 /PRNewswire/ -- In a move heralded by many local AIDS prevention and treatment activists as groundbreaking, the West Hollywood city council -- overriding its own city staff & human services commission s recommendation -- voted 3 to 2 Tuesday to instruct staff to draft a plan for manda
PITTSBURGH, July 2 /PRNewswire/ -- A scientist at the Pittsburgh Supercomputing Center, in collaboration with a team of HIV researchers, simulated the structure and movement of reverse transcriptase (RT), an HIV enzyme targeted by AIDS drugs. The results -- reported in PROTEINS (May 15) -- show a large-scale motion in
NEW YORK, July 2 /PRNewswire/ -- Can HIV be eradicated? Can it become a chronic and manageable disease? What do you say to a loved one who has just told you he/she has contracted HIV? What are the latest HIV treatment advances, and how can a person optimize their use? Where are future research directions? These are jus
ABBOTT PARK, Ill., June 30 /PRNewswire/ -- Abbott Laboratories (NYSE: ABT - news) announced today it has received U.S. Food and Drug Administration ( FDA ) approval for Norvir ( ritonavir ) soft-gelatin capsules.
DALLAS, June 25 /PRNewswire/ -- The following was released by TAHFIN: TAHFIN members monitor public Internet web sites, newsgroups and broadcasted e-mail messages regularly. We identify potential scams and the promotion of suspect fraudulent treatments. We try to counteract obvious misinformation in the same forum by s
TORONTO, June 29 /PRNewswire/ -- Visible Genetics Inc. (VGI) (Nasdaq: VGIN - news) announced today that it is introducing a new product known as TruPrep(TM) for RNA extraction that makes genotyping possible for ultra-low level viral load HIV patients. The new product which will be available for research use only, was d
CHICAGO, June 29 /PRNewswire/ -- The Female Health Company (OTC Bulletin Board: FHCO - news) today announced, in conjunction with the June 22, 1999, announcement by the Joint United National Programme on HIV/AIDS ( UNAIDS ) that UNAIDS is launching the second phase of its unique public/private collaboration with the co
WALTHAM, Mass., June 28 /PRNewswire/ -- More than 1.3 million people in the world s seven major pharmaceutical markets (the United States , France , Germany , Italy , Spain , the United Kingdom , and
LOS ANGELES, June 25 /PRNewswire/ -- Eighteen years ago, a report by UCLA scientist Michael Gottlieb published by the Center for Disease Control and Prevention alerted physicians to an unusual constellation of fungal infections and pneumonia in otherwise healthy young gay men. The condition was later named the acquired
PHILADELPHIA, June 25 /PRNewswire/ -- Hundreds of demonstrators from the AIDS, African American and gay and lesbian communities are expected to participate in a demonstration next Monday, June 28th, outside a $1,000 per person fundraiser for the Gore for President campaign, according to ACT UP Philadelphia. The general
TORONTO, June 25 /PRNewswire/ -- Visible Genetics Inc. (VGI) (Nasdaq: VGIN - news), announced today that the June 26th issue of The Lancet (Vol. 352, No. 9171) reports that drug selection based on genotyping is effective in producing a statistically significant benefit in lowering the viral loads of HIV patients who we
BERKELEY, Calif., June 25 /PRNewswire/ -- With the availability of the urine HIV-1 test method, people now have a painless, non-invasive, safe and convenient option for getting an HIV test. And, the scientific and health care communities have another important tool in the fight against HIV/AIDS. Following are key facts
LAVAL, Quebec, June 24 /CNW-PRN/ - BioChem Pharma Inc. (NASDAQ: BCHE - news; ME, TSE: BCH - news) announced today that results from an analysis of five HIV clinical trials suggest that Epivir (lamivudine), also known as 3TC ®, continues to have antiviral activity in HIV patients whose virus dev
HOFFMAN ESTATES, Ill., June 24 /PRNewswire/ -- Home Access Health Corporation executives today applauded the Federal Trade Commission s Operation Cure-All to combat deceptive health claims on the Internet. The Internet puts a world of information at a person s fingertips, said Richard A. Quattrocchi, president of Home
TORONTO, June 24 /PRNewswire/ -- (VGI) (Nasdaq: VGIN - news) Clinical data from the Visible Genetics Inc. sponsored clinical trial, VIRADAPT, presented today at the 3rd International Workshop on Drug Resistance and Treatment Outcomes in San Diego, California, supports the already reported six-month study data -- that d
SOUTH SAN FRANCISCO, Calif., June 23 /PRNewswire/ -- ViroLogic, Inc., a biotechnology company developing novel therapy guidance technology for viral diseases and cancer, today announced the commercial availability of PhenoSense(TM) HIV, the company s rapid phenotypic HIV drug resistance assay. In a time of rising HIV d
CAMBRIDGE, Mass., June 23 /PRNewswire/ -- Agenerase (TM) ( amprenavir ), the latest protease inhibitor to be approved by the U.S. Food and Drug Administration for use in combination with other antiretrovirals for the treatment of HIV infection, is now available in a flavored oral solution.
RANCHO BERNARDO INN, Calif., June 23 /PRNewswire/ -- Results of an in vitro study suggest that tipranavir, the first in a new class of non-peptidic protease inhibitors (PIs), is active against strains of HIV that are highly resistant to all four protease inhibitors approved for use at the time of the study. In fact, 90
ATLANTA, June 21 /PRNewswire/ -- The Centers for Disease Control and Prevention (CDC) joins the National Association of People with AIDS (NAPWA), the National Alliance of State and Territorial AIDS Directors (NASTAD) and other organizations to support the annual National HIV Testing Day campaign. The aim of this campai
WASHINGTON, June 21 /PRNewswire/ -- To help identify approximately 900,000 people in the United States who may be infected with HIV, the virus that causes AIDS, the National Association of People with AIDS (NAPWA) announced today the fifth annual National HIV Testing Day, June 27. This week across the nation, free and
NEW YORK, June 7 /PRNewswire/ -- In the July issue of Seventeen Magazine, senior writer Gayle Forman concludes, after extensive research, that if you re a kid with HIV living in an impoverished country ... pretty much the only thing you can be sure of is that you re going to die soon. Forman looked closely at how teens
SAN FRANCISCO, June 3 /PRNewswire/ -- In a free, interactive telephone teleconference on Monday, June 7, 5 PM Pacific Time (8 PM Eastern), three frontline HIV clinician/researchers -- Donald Kotler, MD, David Hardy, MD, and Stephen Becker, MD -- will review and answer questions about the 9th annual Clinical Care Option
WILMINGTON, Del., June 1 /PRNewswire/ -- DuPont Pharmaceuticals announced today that the European Commission has granted full marketing authorization for its anti-HIV drug, Sustiva (TM) ( efavirenz ) in Europe. Sustiva is the first once-daily anti-HIV drug to receive full marketing authorization
CHICAGO, May 29 /PRNewswire/ -- Life saving drug therapies for HIV-infected patients should be chosen and monitored carefully to ensure they provide maximum suppression of viral replication to stem the increasing prevalence of drug-resistant strains of HIV, a leading virologist reported today. HIV-infected patients are
ST. PAUL, Minn., May 27 /PRNewswire/ -- Scientists at the Hughes Institute report the discovery of a new drug known as HI-236 which is highly effective against multi-drug resistant AIDS virus. This report will appear May 27 issue of Bioorganic & Medicinal Chemistry Letters. Despite development of a number of promis
VANCOUVER, May 27 /CNW-PRN/ - AnorMED Inc. (TSE: AOM - news) announced today that it has opened enrollment in a Phase II clinical trial for its HIV treatment AMD-3100. The trial is being conducted in HIV-infected patients at three centres in the United States and is designed to test the safety, pharmacokinetics and ant
TARRYTOWN, N.Y., and FREMONT, Calif., May 19 /PRNewswire/ -- Protein Design Labs, Inc. (PDL) (Nasdaq: PDLI - news) and Progenics Pharmaceuticals, Inc. (Progenics) (Nasdaq: PGNX - news) today announced an agreement for the humanization by PDL of PRO 140, Progenics novel anti-CCR5 monoclonal antibody that potently blocks
TORONTO, May 19 /PRNewswire/ -- Visible Genetics Inc. (VGI) (Nasdaq: VGIN - news) announced today, following FDA protocol review, that it will proceed under its December 1998 Investigational Device Exemption (IDE) with Vigilance II, a US based open label, cost recovery HIV Genotyping study. Vigilance II will use VG
CHICAGO, May 18 /PRNewswire/ -- The American College of Occupational and Environmental Medicine (ACOEM) and the American Association of Occupational Health Nurses, Inc. (AAOHN) have issued their support of legislation introduced by Sen. Robert Bennett (R-Utah) on April 26. Sen. Bennett s Bill 881, known as The Medical
DURHAM, N.C., May 18 /PRNewswire/ -- Today at the Digestive Disease Week meeting in Orlando, Florida, Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS - news) is presenting preliminary data from a completed Phase I/II dose-escalation study of the safety, tolerance, pharmacokinetics and anti-hepatitis B (HBV) activity of Co
NEW YORK, May 17 /PRNewswire/ -- The American Foundation for AIDS Research (amfAR) today announced $1.7 million in grants to support AIDS vaccine research and research on immune reconstitution (restoring the normal functioning of immune systems damaged by HIV). The announcement comes on the eve of AIDS Vaccine Awarenes
NEW YORK, May 17 /PRNewswire/ -- At the 12th World AIDS Conference in Geneva this past year the clinical necessity for immune reconstitution for patients living with HIV became a priority as the implications of viral resistance produced projections of almost universal failure of the present classes of antiretrovirals i
CARLSBAD, Calif. and LA JOLLA, Calif., May 17 /PRNewswire/ -- The Immune Response Corporation (Nasdaq: IMNR - news) and Agouron Pharmaceuticals, Inc. (Nasdaq: AGPH - news) announced today that an independent Data Safety Monitoring Board (DSMB) completed a second interim analysis of the 2500-patient, placebo-controlled,
SACRAMENTO, Calif., May 14 /PRNewswire/ -- The California HIV Advocacy Coalition (CHAC) applauded Governor Davis revised budget proposal for FY 1999 - 2000, which was released today. The Governor s proposal ensures full funding for the California AIDS Drug Assistance Program (ADAP), which provides life-prolonging HIV/A
WASHINGTON, May 11 /PRNewswire/ -- One year ago today, after a meeting with African American AIDS activists, health care providers, and leaders of community based organizations from across the country, the Congressional Black Caucus (CBC) urged the Secretary of the U.S. Department of Health and Human Services to declar
NEW YORK, May 11 /PRNewswire/ -- The following is being issued by Asensio & Company, a member of the National Association of Securities Dealers, CRD number 31742: A Hemispherx Biopharma, Inc. (Amex: HEB - news) report recently issued by Value Management & Research AG ( VMR ), a Germany-based asset-management fi
ABBOTT PARK, Ill. and NEW YORK, May 11 /PRNewswire/ -- Most people agree it is important to have others you can count on and this is especially true if you are a person living with HIV. A strong support network can help individuals with HIV more effectively manage their illness. Additionally, research suggests that a s
SAN DIEGO, May 6 /PRNewswire/ -- Hollis-Eden Pharmaceuticals (Nasdaq: HEPH - news) announced today it has begun a Phase I/II clinical trial with its lead investigational drug candidate HE2000 for the treatment of HIV/AIDS in South Africa with US clinical trials to follow. The Company s scientific and regulatory team ha
DETROIT, May 5 /PRNewswire/ -- In a fitting launch to National Nurses Week, SEIU Local 79 members will be in Lansing tomorrow morning in support of new legislation that would require the use of safety needles in all healthcare facilities throughout Michigan. SEIU Local 79, representing 17,000 members statewide, is pled
GENEVA, May 4 /PRNewswire/ -- Vitry sur Seine/International Exhibition of Inventions -- Caleb, the invention perfected by A.R. Commin appears as a new precious allied in the fight against diseases caused by retroviruses and, most particularly AIDS, when other antivirals which efficiency was proved, show their limits in
SAN FRANCISCO, May 4 /PRNewswire/ -- Mayor Willie L. Brown Jr. today challenged national and local businesses to join with the City of San Francisco and DuPont Pharmaceuticals Company in a new initiative aimed at preventing the spread of HIV and AIDS in San Francisco. DuPont Pharmaceuticals is leading the five-year ini
SAN FRANCISCO, May 4 /PRNewswire/ -- Three prominent HIV experts who helped create the U.S. government-endorsed HIV Treatment Guidelines will discuss and answer questions about the latest revisions to the Guidelines during a telephone teleconference on May 10 at 4 p.m. Eastern Time (1 p.m. Pacific). Produced by the HIV
SEATTLE, and VICTORIA, British Canada , May 3 /PRNewswire/ -- Immunex Corporation (Nasdaq: IMNX - news) announced today that LEUKINE (sargramostim; GM-CSF) maintained viral suppression and extended the duration of antiretroviral therapy utility in patients with AIDS whose viral loads were less than 30,000 copies/mL at
NEW YORK, May 3 /PRNewswire/ -- The International AIDS Vaccine Initiative (IAVI) announced Monday that it has received a US$25 million grant, the largest charitable gift in the history of the AIDS pandemic, from the William H. Gates Foundation. IAVI will more than double its AIDS vaccine development efforts as a result
WEST BRIDGEWATER, Mass., May 3 /PRNewswire/ -- Boston Biomedica, Inc. (Nasdaq: BBII - news) announced today that Dr. Carl Wild, Principal Scientist at BBI Biotech Research Laboratories (a wholly owned subsidiary of Boston Biomedica) has been invited to present the latest results of Boston Biomedica s novel approach to
LOS ANGELES, April 30 /PRNewswire/ -- Following yesterday s release of a long-awaited -- and blistering -- City Controller s report documenting widespread mismanagement of L.A. s city-run, federally funded H.O.P.W.A. (Housing Opportunities for Persons With AIDS) program, a group of AIDS and homeless activists led by AI
WEST BRIDGEWATER, Mass., April 29 /PRNewswire/ -- Boston Biomedica, Inc. (Nasdaq: BBII - news) announced today that it has signed new Sponsored Research (SR) and License Agreements with the University of North Carolina at Chapel Hill that build on BBI s HIV drug discovery program and expand the Company s rights into ot
PHILADELPHIA, April 28 /PRNewswire/ -- Democratic mayoral candidate John Street has called on state health department officials to use codes, also called unique identifiers, in tracking the level of HIV infection in Pennsylvania, rather than the names of those infected. Citing the fact that too often those with HIV/AID
TARRYTOWN, N.Y., April 26 /PRNewswire/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX - news) today announced publication of a scientific article describing PRO 140 (PA14), a novel monoclonal antibody (MAb) with potent anti-HIV activity. The article appears in the May issue of the Journal of Virology (vol. 73, no. 5,
WASHINGTON, April 21 /PRNewswire/ -- Nearly one out of every three new HIV infections occur in women, according to recent studies. So why do women account for only nine to 15% of research study participants? And do we know if men and women respond the same way to anti-HIV drug therapies? At Whitman-Walker Clinic in Was
CHICAGO, April 21 /PRNewswire/ -- The American Civil Liberties Union today announced a favorable settlement in the U.S. District Court ending the lawsuit Doe v. Glen Ellyn Clinic which the ACLU filed last year. This case concerned discrimination and invasion of privacy that Plaintiffs Jimmy Doe and Mary Doe -- who are
RESEARCH TRIANGLE PARK, N.C., April 16 /PRNewswire/ -- Glaxo s Agenerase (TM) ( amprenavir ), a new protease inhibitor with proven antiviral activity, has been granted accelerated approval by the U.S. Food and Drug Administration for use in combination with other antiretrovirals for the treatment
LARCHMONT, N.Y., April 14 /PRNewswire/ -- Nitric Oxide (NO), a naturally occurring free radical that is generated by a wide variety of human cells, plays important roles in maintaining host immunity. According to a paper published in the first issue of a new peer reviewed journal, Antioxidants and Redox Signaling, publ
SAN FRANCISCO, April 13 /PRNewswire/ -- In an interactive telephone teleconference on April 15, a panel of HIV treatment experts will discuss and answer questions about the role of the anti-HIV drugs RESCRIPTOR, SUSTIVA, and VIRAMUNE in the management of HIV disease. Recent study results suggest that, when used as part
DALLAS, April 12 /PRNewswire/ -- The Texas AIDS Health Fraud Information Network (TAHFIN) can now be reached toll-free at their new number: 800-758-5152. TAHFIN is a task force sponsored by the US Food and Drug Administration and composed of Community-Based Organizations (CBO), Texas Department of Health (TDH), Federal
SPRINGFIELD, Va., April 13 /PRNewswire/ -- On June 27, National HIV Testing Day, Americans are encouraged to learn their HIV status, and seek appropriate prevention, and health care. For those diagnosed with HIV/AIDS, questions pertaining to appropriate treatment can be complex. Although multiple options are available
PITTSBURGH, April 9 /PRNewswire/ -- Clinical studies to evaluate AIDSVAX(TM), the first-ever preventive HIV/AIDS vaccine to be tested in Phase III human clinical trials, are beginning now at the University of Pittsburgh Medical Center s HIV program, the Pitt Treatment and Evaluation Unit (PTEU). This is the first large
SOUTH SAN FRANCISCO, Calif., April 8 /PRNewswire/ -- OXO Chemie Inc., a subsidiary of OXO Chemie AG of Switzerland announced today the April 6 approval by the Health Protection Branch for the initiation of Canadian sites as the expansion of an ongoing U.S. Phase 3 clinical trial for people with late-stage HIV disease.
CHICAGO, April 8 /PRNewswire/ -- The Female Health Company (OTC Bulletin Board: FHCO - news) today announced it is embarking on an expanded partnership with the Joint United Nations AIDS Programme ( UNAIDS ) to accelerate and expand the availability of the Female Condom in developing countries. The need to acceler
BALTIMORE, Md., April 7 /PRNewswire/ -- On April 28, people living with HIV and AIDS will have the unique opportunity to chat online with a leading expert on the disease. Joel Gallant, MD, MPH, Associate Professor of Medicine in the Division of Infectious Diseases, and Director of the Moore HIV Clinic at the Johns Hopk
ALEXANDRIA, Va., April 6 /PRNewswire/ -- Drinking a glass of grapefruit juice with medications has long been known to help with the body s absorption of certain drugs. However, scientists at the University of California at San Francisco (UCSF) have now found that grapefruit juice may actually have a negative impact on
MINNEAPOLIS, April 6 /PRNewswire/ -- Abbott Northwestern Hospital announced today that Barbara Anderson has accepted the position as program manager of Park House, a community day health program for people with HIV/AIDS. Park House is taking innovative steps toward improving the day health program offered to our client
WASHINGTON, April 5 /PRNewswire/ -- Under pressure from the National Association for People With AIDS (NAPWA) and members of the HIV/AIDS community, the Health Care Finance Administration (HCFA) has reversed an earlier statement that allowed the state of Texas to deny Medicaid reimbursement for Serostim, the first biot
TITUSVILLE, N.J., March 31 /PRNewswire/ -- Sporanox® (itraconazole) Injection, a new, intravenous treatment for several difficult-to-treat, potentially life-threatening fungal infections, was approved March 30 by the U.S. Food and Drug Administration, announced officials of Janssen Pharmaceutica. Sporanox Injection is
ABBOTT PARK, Ill., March 31 /PRNewswire/ -- Abbott Laboratories today announced it has submitted an application to the U.S. Food and Drug Administration ( FDA ) seeking approval for Norvir ® ( ritonavir ) soft-gel capsules.
BALTIMORE, March 30 /PRNewswire/ -- The Multicenter AIDS Cohort (MACS) study that has followed a group of 5,622 homosexual and bisexual men nationwide to determine if, when, and why they contract human immunodeficiency virus (HIV) will reach its fifteen-year milestone on March 31, 1999. Among the achievements of the MA
INDIANAPOLIS, March 30 /PRNewswire/ -- Community Medical Research Institute of Community Hospitals Indianapolis, is now inoculating volunteers in the North American trial of AIDSVAX, the first-ever vaccine against HIV to be tested in Phase III clinical trials. This is the only site in Indiana and the Ohio Valley region
TARRYTOWN, N.Y., March 30 /PRNewswire/ -- Chiron Diagnostics, a business unit of Bayer Diagnostics, announced today that they have initiated the Premarket Approval Application (PMA) process for the Quantiplex® HIV-1 RNA 3.0 Assay (bDNA). The test incorporates third generation branched DNA (bDNA) technology for highly s
LAVAL, Quebec, March 24 /CNW/ - BioChem Pharma Inc. (NASDAQ: BCHE; ME, TSE: BCH) today announced that the U.S. Food and Drug Administration granted approval for expanded prescribing information on the use of Epivir (R) (lamivudine), also known as 3TC (R), in infants, chi
WILMINGTON, Del., March 23 /PRNewswire/ -- DuPont Pharmaceuticals, a component of DuPont s Life Sciences Enterprise, announced today that its anti-HIV drug, Sustiva (TM) ( efavirenz ), was approved by the Canadian Health Protection Branch (HPB), making the drug available soon to individuals in th
WASHINGTON, March 22 /PRNewswire/ -- Can Increasing Self-Esteem Help to Decrease HIV/AIDS and Substance Abuse Among African American Youth? That is the question renowned African American Harvard Psychiatrist Dr. Alvin Poussaint will put before a Community Town Hall Meeting of Historically Black Colleges and Universitie
BERLIN, March 22 /PRNewswire/ -- Data presented today show that Sustiva (TM) ( efavirenz ), DuPont Pharmaceuticals once-daily non-nucleoside reverse transcriptase inhibitor (NNRTI), when taken in combination with stavudine (
WASHINGTON, March 17 /PRNewswire/ -- Today the Institute of Medicine (IOM) released its report Marijuana and Medicine: Assessing the Science Base. The report was prompted by a request from the Office of National Drug Control Policy (ONDCP) to explore the potential medical benefits and risks of marijuana. The IOM report
BALTIMORE, March 16 /PRNewswire/ -- When the first National Conference on African Americans and AIDS sold out its 750 slots, leaving 600 doctors and public health professionals on the waiting list, organizers decided to bring the conference to them -- and everyone -- via the Internet. The Netcast is a way to include ev
NEW ORLEANS, March 15 /PRNewswire/ -- Jurors awarded $35.3 million to Leo and Shirley Dixon for the death of their son, Ken Dixon, who was infected with the HIV virus and contracted AIDS for the treatment he used for his hemophilia condition. This trial, concerning Hemophiliac AIDS Cases, began on November 4, 1998 in S
LOS ANGELES, March 12 /PRNewswire/ -- AIDS Healthcare Foundation s (AHF s) 1999 California legislative agenda re-introduces HIV healthcare concepts previously approved by the Legislature -- only to be vetoed by former Governor Pete Wilson. We re optimistic the Davis era will mean real advances in statewide access to qu
SAN DIEGO, March 11 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH - news) today announced that they have been approved by the South African Medicine Control Council (MCC) to initiate testing with their lead drug candidate, HE2000, in HIV/AIDS patients. This allows the Company to evaluate HE2000 in pat
WILMINGTON, Del., March 9 /PRNewswire/ -- DuPont Pharmaceuticals announced today that Pennsylvania and Texas have added Sustiva (TM) ( efavirenz ), the first once-daily anti-HIV treatment, to their state assistance program drug formularies, bringing the total to 48 states that have included the d
SAN DIEGO, March 1 /PRNewswire/ -- Hollis-Eden Pharmaceuticals, Inc. (Nasdaq: HEPH - news) today announced that the U.S. Food and Drug Administration ( FDA ) has notified the company that they may initiate dosing in a U.S. Phase I/II clinical trial for HE2000, an investigational new drug for the treatment of HIV/AIDS.
WASHINGTON, Feb. 25 /PRNewswire/ -- AIDS is the leading killer of African- American males between the ages of 25 and 44 and is the second leading killer of African-American women in the same group. Alarmingly, while the overall number of deaths from AIDS fell in the U.S. in 1997 by 47 percent, the same dramatic decreas
DALLAS, Feb. 24 /PRNewswire/ -- Texans living with HIV and AIDS now have a new resource on the Internet at www.tahfin.org thanks to the Texas AIDS Health Fraud Information Network (TAHFIN), a statewide task force sponsored by the U.S. Food and Drug Administration. The web site provides up-to-date news, resources, links
HARRISBURG, Pa., Feb. 23 /PRNewswire/ -- The Department of Health will hold public hearings concerning HIV reporting in Pennsylvania on Wednesday, Feb. 24, at the Westmoreland County Community College in Greensburg, and Thursday, Feb. 25, at City Hall in Meadville, Crawford County. The public hearings will be from 1 p.
LOS ANGELES, Feb. 9 /PRNewswire/ -- The State of California has agreed to a $250,000 settlement of a federal lawsuit brought by AIDS Healthcare Foundation (AHF), the nation s largest HIV/AIDS medical provider. AHF filed the lawsuit in Federal Court, Central District of California [CV-97-3235-LGB (Mcx)], in May 1997 fol
LYON, France , Feb. 8 /PRNewswire/ -- Pasteur Merieux Connaught (Rhone-Poulenc Group) today announced that the first AIDS vaccine trial in Africa has started, using the company s ALVAC-HIV (vCP205) canarypox vaccine. The candidate vaccine, which will be given to 40 healthy volunteers in
WEST POINT, Pa., Feb. 5 /PRNewswire/ -- Editor s Note: This news release is related to presentations about Crixivan ®, Merck & Co. , Inc. s (NYSE: MRK - news) protease inhibitor for the treatment of HIV disease and AIDS, at the 6th Conference on Retroviruses and Opportunistic Infections earlier this week in Chicago
CHICAGO, Feb. 4 /PRNewswire/ - Data presented today show that anti-HIV therapy including DuPont Pharmaceuticals once-daily Sustiva (TM) ( efavirenz ) instead of the protease inhibitor, Crixivan ® (
BRIDGEWATER, N.J. Feb. 3 /PRNewswire/ -- The newly announced results of AIDS Clinical Trial Group Study 370 (ACTG 370), which compared RESCRIPTOR or 3TC in protease inhibitor (PI)-containing triple combinations in nucleoside analogue-experienced patients, showed all treatment arms demonstrated sustained suppression of
CHICAGO, Feb. 3 /PRNewswire/ -- New laboratory study results suggest that the effect of the investigational protease inhibitor Agenerase (TM) ( amprenavir ) on several metabolic processes associated with lipodystrophy is negligible. Lipodystrophy (abnormal redistribution of fat throughout the bod
CHICAGO, Feb. 3 /PRNewswire/ -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX - news) today announced its discovery of an anti-CCR5 monoclonal antibody that potently blocks HIV replication in the laboratory. In a separate development, Progenics described the completion and preliminary findings of its Phase I/II clinica
BRIDGEWATER, N.J., Feb. 3 /PRNewswire/ -- Preliminary study results from an ongoing clinical trial suggest using RESCRIPTOR® ( delavirdine mesylate tablets, DLV) with the protease inhibitor indinavir (IDV) significantly decreases viral load in triple or quadruple combination therapy with zidovu
LA JOLLA, Calif., Feb. 3 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. (Nasdaq: AGPH - news) today announced preliminary results from an ongoing women s study called Women First, to evaluate the safety, efficacy, and tolerability of the HIV protease inhibitor VIRACEPT® (nelfinavir mesylate) in combination therapy speci
NEW YORK, Feb. 2 /PRNewswire/ -- Despite solid scientific evidence that syringe exchange programs reduce the spread of HIV and do not encourage drug use, New Jersey s Gov. Christine Todd Whitman points to a study by the right-wing Heritage Foundation as her evidence against syringe exchanges, according to an article in
CHICAGO, Feb. 2 /PRNewswire/ -- Agenerase (TM) ( amprenavir ), a novel HIV protease inhibitor administered twice daily, is a potent drug with few significant side effects, according to preliminary data from several ongoing clinical trials presented this week at a major AIDS research conference in
BRIDGEWATER, N.J., Feb. 2 /PRNewswire/ -- Researchers presented preliminary in vitro data today that showed clinical isolates obtained from HIV-1 infected patients treated with RESCRIPTOR® ( delavirdine mesylate tablets, DLV) plus zidovudine ( AZT ) were susceptible to two m
CHICAGO, Feb. 1 /PRNewswire/ -- Data presented today at a leading AIDS meeting in Chicago suggest that the investigational drug Agenerase (TM) ( amprenavir ) has a different resistance profile from other protease inhibitors that potentially aff
CHICAGO, Feb. 1 /PRNewswire/ -- New research presented today at the 6th Conference on Retroviruses and Opportunistic Infections shows that two of DuPont Pharmaceuticals second generation non-nucleoside reverse transcriptase inhibitors (NNRTIs) appear to be active against NNRTI-resistant strains of HIV. These compounds
LANSING, Mich., Feb. 1 /PRNewswire/ -- Attorney General Jennifer M. Granholm announced today that she has ordered National Vaccine Information Center of Vienna, Virginia, to cease sending misleading and deceptive solicitations to Michigan citizens. Granholm took the action after receiving copies of mailings giving the
CHICAGO, Feb. 1 /PRNewswire/ -- Study results presented today indicate that Ziagen (TM) ( abacavir sulfate), in combination with Epivir (lamivudine, also known as 3TC ) and
LA JOLLA, Calif., Feb. 1 /PRNewswire/ -- Agouron Pharmaceuticals, Inc. (Nasdaq: AGPH - news) today reported potent in vitro antiviral activity against both wild-type and resistant HIV strains for two investigational compounds being developed by the company. Results will be presented by scientists this week at the 6th C
CHICAGO, Feb. 1 /PRNewswire/ -- Treatment with the anti-HIV drug combinations of Ziagen (TM) ( abacavir sulfate)+ Combivir ® (lamivudine/zidovudine) and Crixivan (
ABBOTT PARK, Ill., Feb. 1 /PRNewswire/ -- Abbott Laboratories (NYSE: ABT - news) advanced-generation protease inhibitor, ABT-378, shows promise according to new data presented at the 6th Conference on Retroviruses and Opportunistic Infections in Chicago. Results showed that greater than or equal to 93 percent of antire
FORT WORTH, Texas, Jan. 28 /PRNewswire/ -- In a paper published in this month s Journal of the American Public Health Association, researchers at the University of North Texas Health Science Center report a high percentage of patients in Tarrant County with tuberculosis (TB) to have coexisting HIV infection. They also
WASHINGTON, Jan. 28 /PRNewswire/ -- First Lady Hillary Rodham Clinton and the Elizabeth Glaser Pediatric AIDS Foundation have honored four of the best and brightest scientists with the 1999 Elizabeth Glaser Scientist Award for their innovative, collaborative and cutting-edge research in pediatric HIV/AIDS. The award re
PHILADELPHIA, Jan. 28 /PRNewswire/ -- Angry consumers and their advocates rallied today to protest Rite Aid s purchase of PCS, a pharmacy benefits management firm. In a press conference held at 12 noon in front of the Philadelphia offices of the Department of Justice (located at the Curtis Center, 6th and Walnut Street
SALT LAKE CITY, Jan. 27 /PRNewswire/ -- Biomune Systems, Inc. (Nasdaq: BIMCD - news) today announced its wholly owned subsidiary Optim Nutrition, Inc. s OPTIMUNE, which containe Che Company s patented whey protein concentrate ProMune(TM), was selected as a nutritional supplement to be studied by the AIDS Clinical Trial
MORRIS PLAINS, N.J., and LA JOLLA, Calif., Jan. 26 /PRNewswire/ -- Warner-Lambert Company (NYSE: WLA - news) today announced a definitive agreement to acquire Agouron Pharmaceuticals, Inc. (Nasdaq: AGPH - news), an integrated pharmaceutical company committed to the discovery and development of innovative therapeutic pr
NEW YORK, Jan. 26 /PRNewswire/ -- A live national teleconference, Altered Body Shape in HIV Disease: A Side Effect of Therapy? sponsored by the AIDS Wasting Foundation, focused on an emerging new syndrome in HIV disease called lipodystrophy that is just beginning to be recognized and understood. The interactive program
WALTHAM, Mass., Jan. 26 /PRNewswire/ -- More than 1.3 million people in the world s seven major pharmaceutical markets (the United States , France , Germany , Italy , Spain , the United Kingdom , and
DURHAM, N.C., Jan. 26 /PRNewswire/ -- Triangle Pharmaceuticals, Inc. (Nasdaq: VIRS - news) announced today that it will be presenting the results of a phase I/II clinical study of the antiviral activity and safety of Coviracil(TM) (emtricitabine) in HIV-infected patients at an upcoming scientific meeting. In this abbre
MINNEAPOLIS, Jan. 25 /PRNewswire/ -- First Circle Medical announced today that its advanced clinical trials are underway at the Doctor s Hospital in New Boston, Texas on a treatment which it believes will reduce human immunodeficiency virus (HIV) in persons with multiple-drug-resistant acquired immunodeficiency syndrom
PRNewswire - Wednesday January 13, 8:31 am Eastern Time
VIENNA, Va., Jan. 13 /PRNewswire/ -- CEL-SCI CORPORATION (Amex: HIV; Berlin Stock Exchange: LSR) has received numerous inquiries regarding a recent report by Johns Hopkins University investigators describing new findings of a key part of the AIDS virus in India . Their report suggests that there may be problems in the
SAN FRANCISCO, Jan. 11 /PRNewswire/ -- In a free, interactive telephone teleconference, 3 medical experts will discuss and answer questions about unusual body changes experienced by some people taking protease inhibitor drugs to treat HIV/AIDS. Entitled Altered Body Shape in HIV Disease: A Side Effect of Therapy?, the
LOS ANGELES, Jan. 8 /PRNewswire/ -- AIDS Project Los Angeles (APLA) today reacted with disappointment that Governor Davis proposed budget for Fiscal Year 1999-2000 would reduce the state s contribution to funding the health, prevention and social service needs of Californians living with HIV/AIDS. This is a crucial tim
STATE COLLEGE, Pa., Jan. 5 /PRNewswire/ -- In a report published yesterday in Nature Medicine, a team of U.S. scientists based at The University of California at Berkeley and the University of California at San Francisco announced initial in vivo results of T cell proliferation rates in AIDS patients using novel mass s
PHILADELPHIA, Jan. 5 /PRNewswire/ -- Biosyn, Inc., a drug research and development company, has announced today that patient enrollment has commenced in its Phase I clinical trial of SAVVY™ (glyminox vaginal gel) at the University of Pennsylvania Medical School. This study is partially funded by the NICHD. SAVVY is a v
SEATTLE, Jan. 4 /PRNewswire/ -- Researchers at the Fred Hutchinson Cancer Research Center (FHCRC), the University of Washington (UW) and Targeted Genetics Corp. (Nasdaq: TGEN - news) announced the publication of data from a Phase I study evaluating a new concept in the therapy of HIV-1 infection. The paper, titled In v
This information is designed to support, not replace, the relationship that exists between you and your doctor.